<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"
article-type="research-article">






<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Mol Biol Cell</journal-id>
<journal-id journal-id-type="iso-abbrev">Mol. Biol. Cell</journal-id>
<journal-id journal-id-type="hwp">molbiolcell</journal-id>
<journal-id journal-id-type="pmc">mbc</journal-id>
<journal-id journal-id-type="publisher-id">Mol. Bio. Cell</journal-id>
<journal-title-group>
<journal-title>Molecular Biology of the Cell</journal-title>
</journal-title-group>
<issn pub-type="ppub">1059-1524</issn>
<issn pub-type="epub">1939-4586</issn>
<publisher>
<publisher-name>The American Society for Cell Biology</publisher-name>
</publisher>
</journal-meta>
<article-meta><article-id pub-id-type="pmid">24870034</article-id><article-id pub-id-type="pmc">4116298</article-id><?properties open_access?>
<article-id pub-id-type="publisher-id">E13-04-0216</article-id>
<article-id pub-id-type="doi">10.1091/mbc.E13-04-0216</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
<subj-group>
<subject>Cell Biology of Disease</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Genome-wide analysis of <italic>Saccharomyces cerevisiae</italic> identifies cellular
processes affecting intracellular aggregation of Alzheimer's amyloid-&#x003b2;42: importance of
lipid homeostasis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Nair</surname>
<given-names>S.</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>a</sup></xref>
<xref ref-type="fn" rid="FN1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Traini</surname>
<given-names>M.</given-names>
</name>
<xref ref-type="aff" rid="aff2"><sup>b</sup></xref>
<xref ref-type="fn" rid="FN1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dawes</surname>
<given-names>I. W.</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>a</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>c</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Perrone</surname>
<given-names>G. G.</given-names>
</name>
<xref ref-type="aff" rid="aff4"><sup>d</sup></xref>
<xref ref-type="corresp" rid="cor1"><sup>1</sup></xref>
</contrib>
<aff id="aff1"><sup>a</sup>School of Biotechnology and Biomolecular Sciences, University of New
South Wales, Sydney, NSW 2052, Australia</aff>
<aff id="aff3"><sup>c</sup>Ramaciotti Centre for Gene Function Analysis, University of New South
Wales, Sydney, NSW 2052, Australia</aff>
<aff id="aff2"><sup>b</sup>Atherosclerosis Laboratory, ANZAC Research Institute, Concord Hospital,
Concord, NSW 2139, Australia</aff>
<aff id="aff4"><sup>d</sup>School of Science and Health, University of Western Sydney, Penrith, NSW
1797, Australia</aff>
</contrib-group>
<contrib-group>
<contrib contrib-type="editor">
<name>
<surname>Boone</surname>
<given-names>Charles</given-names>
</name>
<role>Monitoring Editor</role>
</contrib>
<aff>University of Toronto</aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><sup>1</sup>Address correspondence to: Gabriel G. Perrone
(<email>g.perrone@uws.edu.au</email>).</corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>01</day>
<month>8</month>
<year>2014</year>
</pub-date>
<volume>25</volume>
<issue>15</issue>
<fpage>2235</fpage>
<lpage>2249</lpage>
<history><date date-type="received">
<day>26</day>
<month>4</month>
<year>2013</year>
</date><date date-type="rev-recd">
<day>20</day>
<month>5</month>
<year>2014</year>
</date><date date-type="accepted">
<day>20</day>
<month>5</month>
<year>2014</year>
</date></history>
<permissions>
<copyright-statement>&#x000a9; 2014 Nair, Traini, <italic>et&#x000a0;al.</italic> This article is
distributed by The American Society for Cell Biology under license from the author(s). Two months
after publication it is available to the public under an
Attribution&#x02013;Noncommercial&#x02013;Share Alike 3.0 Unported Creative Commons License
(<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"
>http://creativecommons.org/licenses/by-nc-sa/3.0</ext-link>).</copyright-statement>
<copyright-year>2014</copyright-year>
<license license-type="creative-commons">
<license-p>&#x0201c;ASCB&#x000ae;,&#x0201d; &#x0201c;The American Society for Cell
Biology&#x000ae;,&#x0201d; and &#x0201c;Molecular Biology of the Cell&#x000ae;&#x0201d; are
registered trademarks of The American Society of Cell Biology.</license-p>
</license>
</permissions>
<self-uri xlink:title="pdf" xlink:type="simple" xlink:href="2235.pdf"/>
<abstract abstract-type="precis">
<p>Aggregation of intracellular amyloid-&#x003b2; (A&#x003b2;) is an early event in Alzheimer's
disease. Here A&#x003b2;42 fused to GFP was expressed in each mutant of a <italic>Saccharomyces
cerevisiae</italic> genome-wide deletion library to identify cellular processes affecting
intracellular A&#x003b2;42 aggregation by assessing fluorescence of the A&#x003b2;42-GFP fusion.</p>
</abstract>
<abstract>
<p>Amyloid-&#x003b2; (A&#x003b2;)&#x02013;containing plaques are a major neuropathological feature
of Alzheimer's disease (AD). The two major isoforms of A&#x003b2; peptide associated with AD are
A&#x003b2;40 and A&#x003b2;42, of which the latter is highly prone to aggregation. Increased
presence and aggregation of intracellular A&#x003b2;42 peptides is an early event in AD progression.
Improved understanding of cellular processes affecting A&#x003b2;42 aggregation may have
implications for development of therapeutic strategies. A&#x003b2;42 fused to green fluorescent
protein (A&#x003b2;42-GFP) was expressed in &#x0223c;4600 mutants of a <italic>Saccharomyces
cerevisiae</italic> genome-wide deletion library to identify proteins and cellular processes
affecting intracellular A&#x003b2;42 aggregation by assessing the fluorescence of A&#x003b2;42-GFP.
This screening identified 110 mutants exhibiting intense A&#x003b2;42-GFP&#x02013;associated
fluorescence. Four major cellular processes were overrepresented in the data set, including
phospholipid homeostasis. Disruption of phosphatidylcholine, phosphatidylserine, and/or
phosphatidylethanolamine metabolism had a major effect on intracellular A&#x003b2;42 aggregation and
localization. Confocal microscopy indicated that A&#x003b2;42-GFP localization in the phospholipid
mutants was juxtaposed to the nucleus, most likely associated with the endoplasmic reticulum (ER)/ER
membrane. These data provide a genome-wide indication of cellular processes that affect
intracellular A&#x003b2;42-GFP aggregation and may have important implications for understanding
cellular mechanisms affecting intracellular A&#x003b2;42 aggregation and AD disease progression.</p>
</abstract>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>INTRODUCTION</title>
<p>Amyloid-&#x003b2; (A&#x003b2;) plaques are a neuropathological feature of Alzheimer's disease
(AD). These extracellular plaques are primarily composed of A&#x003b2; peptide aggregates generated
via amyloidogenic processing of the amyloid precursor protein (APP). According to the amyloid
cascade hypothesis, the A&#x003b2; peptide may play a role in AD pathology through oligomerization
of the peptide. The oligomers may be directly neurotoxic or may mediate toxicity by induction of
stress and hyperphosphorylation of protein tau, leading to tau aggregation into neurofibrillary
tangles, cell loss, vascular damage, and dementia (<xref rid="B30" ref-type="bibr">Glenner and Wong,
1984</xref>; <xref rid="B70" ref-type="bibr">Masters <italic>et&#x000a0;al</italic>., 1985</xref>;
<xref rid="B85" ref-type="bibr">Selkoe, 1991</xref>; <xref rid="B38" ref-type="bibr">Hardy and
Higgins, 1992</xref>). Protein tau is a microtubule-associated protein that influences assembly and
stabilization of microtubules. The tau protein is the main component of neurofibrillary threads and
tangles (NFTs), and there is evidence supporting a key role of tau in the pathophysiology of AD. It
remains to be elucidated whether tau is a bystander of amyloid toxicity or a primary mediator
neurodegeneration in AD. Two major A&#x003b2;-peptide isoforms, A&#x003b2;40 and A&#x003b2;42, are
generated by the amyloidogenic processing of APP, of which the latter is more hydrophobic, highly
prone to aggregation and fibril formation, and more neurotoxic (<xref rid="B45" ref-type="bibr"
>Jarrett <italic>et&#x000a0;al</italic>., 1993</xref>). A&#x003b2;42 is the predominant form of
A&#x003b2; found in neurons (<xref rid="B31" ref-type="bibr">Gouras <italic>et&#x000a0;al</italic>.,
2000</xref>, <xref rid="B32" ref-type="bibr">2005</xref>) and in the extracellular plaques of AD
brains (<xref rid="B107" ref-type="bibr">Younkin, 1998</xref>).</p>
<p>It is not clear whether extracellular aggregates (e.g., plaques) of A&#x003b2; lead to a
protective, inert, or pathogenic mechanism. However, soluble oligomeric forms of A&#x003b2;, rather
than monomeric or fibrillar forms, are the most neurotoxic species (<xref rid="B32" ref-type="bibr"
>Gouras <italic>et&#x000a0;al</italic>., 2005</xref>; <xref rid="B62" ref-type="bibr">Lesne and
Kotilinek, 2005</xref>; <xref rid="B61" ref-type="bibr">Lesne <italic>et&#x000a0;al</italic>.,
2006</xref>), and an increase of soluble oligomeric forms of A&#x003b2;42 may be an early event in
AD progression (<xref rid="B32" ref-type="bibr">Gouras <italic>et&#x000a0;al</italic>.,
2005</xref>). The role of intracellular A&#x003b2; has received increased attention (<xref rid="B35"
ref-type="bibr">Haass and Selkoe, 2007</xref>; <xref rid="B58" ref-type="bibr">LaFerla
<italic>et&#x000a0;al</italic>., 2007</xref>). A&#x003b2;42 was found in multivesicular bodies
(MVBs) of neuronal cells, where it was implicated in synaptic pathology (<xref rid="B93"
ref-type="bibr">Takahashi <italic>et&#x000a0;al</italic>., 2002</xref>). The peptide localizes to
the outer membranes of MVBs (<xref rid="B93" ref-type="bibr">Takahashi
<italic>et&#x000a0;al</italic>., 2002</xref>; <xref rid="B59" ref-type="bibr">Langui
<italic>et&#x000a0;al</italic>., 2004</xref>) and is most often located in the perinuclear region
(<xref rid="B59" ref-type="bibr">Langui <italic>et&#x000a0;al</italic>., 2004</xref>). A&#x003b2;
accumulation also directly inhibits the proteasome (<xref rid="B80" ref-type="bibr">Oh
<italic>et&#x000a0;al</italic>., 2005</xref>; <xref rid="B2" ref-type="bibr">Almeida
<italic>et&#x000a0;al</italic>., 2006</xref>), indicating that soluble A&#x003b2; may be responsible
for induction of toxicity, which may increase with impaired proteasomal function. Gradual
accumulation of A&#x003b2; in mitochondria (<xref rid="B69" ref-type="bibr">Manczak
<italic>et&#x000a0;al</italic>., 2006</xref>) has also been associated with diminished activity of
electron transport chain complexes III and IV and reduced rates of oxygen utilization (<xref
rid="B10" ref-type="bibr">Caspersen <italic>et&#x000a0;al</italic>., 2005</xref>). Intracellular
accumulation of A&#x003b2; precedes extracellular plaque formation, and these findings support the
view that it may be an early event in the progression of AD (<xref rid="B32" ref-type="bibr">Gouras
<italic>et&#x000a0;al</italic>., 2005</xref>). The mechanism(s) contributing to the intracellular
aggregation and localization of the A&#x003b2;42 peptide in patients remains unclear. Because
preventing A&#x003b2; aggregation and/or low-order oligomerization has been proposed as a potential
therapeutic method (<xref rid="B32" ref-type="bibr">Gouras <italic>et&#x000a0;al</italic>.,
2005</xref>), improved understanding of cellular processes involved in A&#x003b2;42 aggregation may
help understand AD disease progression and lead to development of therapeutic strategies.</p>
<p>The budding yeast <italic>Saccharomyces cerevisiae</italic> is an important model organism for
understanding many aspects of eukaryotic molecular biology. <italic>S. cerevisiae</italic> has been
exploited to study proteins implicated in neurodegenerative disorders including Huntington's disease
(<xref rid="B103" ref-type="bibr">Willingham <italic>et&#x000a0;al</italic>., 2003</xref>; <xref
rid="B29" ref-type="bibr">Giorgini <italic>et&#x000a0;al</italic>., 2005</xref>) and Parkinson's
disease (<xref rid="B109" ref-type="bibr">Zhang <italic>et&#x000a0;al</italic>., 1994</xref>; <xref
rid="B81" ref-type="bibr">Outeiro and Lindquist, 2003</xref>; <xref rid="B20" ref-type="bibr">Flower
<italic>et&#x000a0;al</italic>., 2005</xref>). Yeast model systems have been exploited to study
toxicity, aggregation, and localization of A&#x003b2; or as facile systems for identification of
compounds influencing A&#x003b2; oligomerization (<xref rid="B109" ref-type="bibr">Zhang
<italic>et&#x000a0;al</italic>., 1994</xref>, <xref rid="B108" ref-type="bibr">1997</xref>; <xref
rid="B56" ref-type="bibr">Komano <italic>et&#x000a0;al</italic>., 1998</xref>; <xref rid="B9"
ref-type="bibr">Caine <italic>et&#x000a0;al</italic>., 2007</xref>; <xref rid="B66" ref-type="bibr"
>Macreadie <italic>et&#x000a0;al</italic>., 2008</xref>; <xref rid="B104" ref-type="bibr">Winderickx
<italic>et&#x000a0;al</italic>., 2008</xref>; <xref rid="B96" ref-type="bibr">Treusch
<italic>et&#x000a0;al</italic>., 2011</xref>). As indicated, protein tau has also been strongly
correlated with several neuropathies, including AD. Studies of wild-type human tau in yeast have
shown that the model system recapitulates several key pathological features of tau, including tau
hyperphosphorylation, attainment of pathological confirmations of tau, and tau aggregation (<xref
rid="B99" ref-type="bibr">Vandebroek <italic>et&#x000a0;al</italic>., 2005</xref>, <xref rid="B98"
ref-type="bibr">2006</xref>). Disruption of yeast Pho85p or Mds1p, which are orthologues of human
glycogen synthase kinase-3B and cdk5, influences formation of pathological phosphoepitopes of tau in
yeast and their binding affinity for microtubules (<xref rid="B98" ref-type="bibr">Vandebroek
<italic>et&#x000a0;al</italic>., 2006</xref>). Furthermore, deletion of <italic>PHO85</italic>
enhances phosphorylation of the S409 residue in wild-type tau but also in tau variants associated
with frontotemporal dementia with parkinsonism (<xref rid="B100" ref-type="bibr">Vanhelmont
<italic>et&#x000a0;al</italic>., 2010</xref>).</p>
<p>Green fluorescent protein (GFP)-fusion protein folding has been exploited to study the kinetics
of A&#x003b2; aggregation in <italic>Escherichia coli.</italic> An aggregation reporter assay based
on fluorescence of a fusion between A&#x003b2;42 and GFP has been developed (<xref rid="B102"
ref-type="bibr">Waldo <italic>et&#x000a0;al</italic>., 1999</xref>). Aggregation of the GFP-fusion
protein before the folding of GFP quenches its fluorescence. Expression of wild-type A&#x003b2;42
fused to GFP led to formation of insoluble aggregates in which GFP was inactive (<xref rid="B106"
ref-type="bibr">Wurth <italic>et&#x000a0;al</italic>., 2002</xref>). Replacement of A&#x003b2;42 in
the fusion protein with the less-aggregation-prone peptide A&#x003b2;40 led to increased
GFP-associated fluorescence. This approach was exploited to identify variants of A&#x003b2;42 that
affect aggregation of A&#x003b2; (<xref rid="B106" ref-type="bibr">Wurth
<italic>et&#x000a0;al</italic>., 2002</xref>; <xref rid="B53" ref-type="bibr">Kim and Hecht,
2005</xref>). Fluorescence intensity of A&#x003b2;-GFP fusions was inversely correlated with the
aggregation propensity of the A&#x003b2; moiety, demonstrating the efficacy of using A&#x003b2;-GFP
fusion-based approaches to identify factors affecting A&#x003b2; aggregation. Yeast cells expressing
A&#x003b2; exhibited lower growth yield and a heat shock response, indicating that A&#x003b2;
fusions cause stress in cells (<xref rid="B9" ref-type="bibr">Caine <italic>et&#x000a0;al</italic>.,
2007</xref>). Yeast can therefore serve as a model system to screen for modifiers of intracellular
A&#x003b2; aggregation, which has relevance in understanding the role of A&#x003b2; in the death of
neuronal cells. Here we exploit an aggregation reporter assay by expressing A&#x003b2;42 fused to
GFP (A&#x003b2;42-GFP) in each mutant of the <italic>S. cerevisiae</italic> genome-wide deletion
library of nonessential genes (<xref rid="B105" ref-type="bibr">Winzeler
<italic>et&#x000a0;al</italic>., 1999</xref>) to identify the cellular processes and metabolites
that affect intracellular A&#x003b2;42 aggregation.</p>
</sec>
<sec sec-type="results">
<title>RESULTS</title>
<sec>
<title>The A&#x003b2;42-GFP fusion protein expressed in wild-type <italic>S</italic>.
<italic>cerevisiae</italic> is not fluorescent, and the less amyloidogenic A&#x003b2;42-GFP variants
exhibit increased fluorescence</title>
<p>In <italic>E. coli</italic>, the fluorescence intensity exhibited by A&#x003b2;-GFP fusions is
inversely correlated with the aggregation propensity of the A&#x003b2; moiety (<xref rid="B106"
ref-type="bibr">Wurth <italic>et&#x000a0;al</italic>., 2002</xref>; <xref rid="B53" ref-type="bibr"
>Kim and Hecht, 2005</xref>). Mutation of A&#x003b2; residues 41 and 42 (I41E/A42P) generated a
variant (A&#x003b2;EP-GFP) that was less aggregation prone and exhibited higher fluorescence than
A&#x003b2;42-GFP or A&#x003b2;40-GFP (<xref rid="B106" ref-type="bibr">Wurth
<italic>et&#x000a0;al</italic>., 2002</xref>). Before commencing genome-wide screening in <italic>S.
cerevisiae</italic>, it was important to determine whether the correlations demonstrated in
<italic>E</italic>. <italic>coli</italic> (<xref rid="B106" ref-type="bibr">Wurth
<italic>et&#x000a0;al</italic>., 2002</xref>; <xref rid="B53" ref-type="bibr">Kim and Hecht,
2005</xref>) between fluorescence and aggregation propensity of A&#x003b2;-GFP fusions could be
recapitulated in <italic>S. cerevisiae</italic> cells.</p>
<p>Wild-type A&#x003b2;42, A&#x003b2;40, or A&#x003b2;EP (A&#x003b2;-I41E/A42P) sequences fused to
the <italic>N</italic>-terminus of GFP were expressed in the cytosol of wild-type <italic>S.
cerevisiae</italic> cells. Microscopic analysis (<xref ref-type="fig" rid="F1">Figure 1A</xref>)
indicated that the proportion of fluorescent cells and relative fluorescence intensity per cell
decreased in the order A&#x003b2;EP-GFP &#x0003e; A&#x003b2;40-GFP &#x0003e; A&#x003b2;42-GFP, which
inversely correlates with the aggregation propensity of the A&#x003b2; moiety of the fusion protein.
In comparison to GFP expression, which yielded fluorescence in &#x0223c;85% of wild-type cells,
expression of A&#x003b2;EP-GFP, A&#x003b2;40-GFP, and A&#x003b2;42-GFP led to fluorescence in
&#x0223c;60, 50, and 5% of cells, respectively (<xref ref-type="fig" rid="F1">Figure 1C</xref>).
Expression of A&#x003b2;EP-GFP led to diffuse fluorescence distributed throughout the cytosol,
whereas expression of A&#x003b2;42-GFP was associated with trace levels of cytosolic fluorescence
and the presence of one to three fluorescent puncta per cell. Relative to A&#x003b2;42-GFP,
expression of A&#x003b2;40-GFP led to an increase in the cytosolic fluorescence intensity and one to
three puncta per cell.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Fluorescence and corresponding light microscope images of wild-type cells expressing a GFP
control vector, A&#x003b2;42-GFP, A&#x003b2;40-GFP, or A&#x003b2;EP-GFP. (A) Wild-type cells
expressing GFP, A&#x003b2;42-GFP, A&#x003b2;40-GFP, or A&#x003b2;EP-GFP were induced in SC-galactose
medium, and fluorescence was analyzed in exponential phase (OD<sub>600</sub> of 1.5). Bar, 5
&#x003bc;m. (B) Western blot analysis (using 6E10 antibody) and quantification of relative band
intensity of soluble (supernatant) and insoluble (pellet) cell extracts from wild-type cells
expressing A&#x003b2;42-GFP, A&#x003b2;40-GFP, and A&#x003b2;EP-GFP grown to exponential phase
(OD<sub>600</sub> of 1.5). A&#x003b2;-GFP bands, &#x0223c;31 kDa. (C) Proportion of fluorescent
wild-type cells expressing A&#x003b2;42-GFP, A&#x003b2;40-GFP, A&#x003b2;EP-GFP, or GFP (correlating
with A). Nine hundred cells were counted per sample, and data shown are averages of three
independent experiments. *<italic>p</italic> &#x0003c; 0.01.</p>
</caption>
<graphic xlink:href="2235fig1"/>
</fig>
<p>To assess whether reduced fluorescence of A&#x003b2;42-GFP relative to A&#x003b2;40-GFP and
A&#x003b2;EP-GFP was due to decreased levels of soluble (nonaggregated) A&#x003b2;-GFP, cells
expressing each of the foregoing A&#x003b2;-GFP fusion constructs were grown to exponential phase in
SC-galactose (inducing) medium and lysed, and soluble and insoluble proteins were fractionated by
ultracentrifugation. A single band of approximately 31-kDa molecular mass reacting with an
anti-A&#x003b2; antibody was detected in the insoluble pellet fraction for all strains (<xref
ref-type="fig" rid="F1">Figure 1B</xref>), corresponding to the predicted size of the A&#x003b2;-GFP
fusion protein. A band of identical molecular mass was also observed in the soluble supernatant
fraction of cells expressing the A&#x003b2;40-GFP and A&#x003b2;EP-GFP fractions. In contrast, no
band could be detected in the supernatant of cells expressing A&#x003b2;42-GFP. This result
indicates that the very low levels of fluorescence in A&#x003b2;42-GFP cells were not due to lack of
expression or complete proteolysis of the fusion protein. In addition, fusion protein levels in the
soluble supernatant fraction were positively correlated with fluorescence, validating use of
A&#x003b2;-GFP fluorescence as measure of the propensity of the fusion protein to form insoluble
aggregates.</p>
<p>It should also be noted that a significant difference in the level of A&#x003b2;42-GFP relative
to A&#x003b2;40-GFP and A&#x003b2;EP-GFP was observed in the insoluble fraction. Because all the
A&#x003b2;-GFP fusions used were expressed from otherwise identical plasmids/promoters, reduced
levels of A&#x003b2;42-GFP in cells likely stemmed from increased degradation of the insoluble
aggregates of A&#x003b2;42-GFP in cells relative to A&#x003b2;40-GFP and A&#x003b2;EP-GFP. This
hypothesis is consistent with other findings in yeast using A&#x003b2; fused to fluorescent
reporters (<xref rid="B36" ref-type="bibr">Hamada <italic>et&#x000a0;al</italic>., 2008</xref>;
<xref rid="B77" ref-type="bibr">Morell <italic>et&#x000a0;al</italic>., 2011</xref>; <xref
rid="B101" ref-type="bibr">Villar-Pique and Ventura, 2013</xref>). The length of the linker sequence
between an aggregation-prone domain and GFP influences the degree to which aggregation or misfolding
inhibits the appearance of fluorescence. Fusion proteins containing longer linker sequences or where
the aggregation-prone region of a multidomain protein is distal to GFP may display robust
fluorescence despite forming aggregates (<xref rid="B36" ref-type="bibr">Hamada
<italic>et&#x000a0;al.</italic>, 2008</xref>). Indeed, <xref rid="B16" ref-type="bibr">D'Angelo
<italic>et&#x000a0;al.</italic> (2013)</xref> introduced an expanded glycine-alanine linker into
their A&#x003b2;-GFP expression construct specifically to ensure that A&#x003b2;-GFP fluorescence
could be observed in the endoplasmic reticulum, after failing to detect a GFP signal from a shorter
linker form. Because our aim was to create a screening platform for which fluorescence was only
observed under conditions in which A&#x003b2; solubility is increased, we used a very short (four
amino acids) linker region between the C-terminus of A&#x003b2; and the N-terminus of GFP.</p>
<p>Expression of each of the respective A&#x003b2;-GFP fusions (and GFP alone) was not associated
with any discernible change in growth rate of wild-type cells (unpublished data). These findings are
consistent with previous findings in which amyloid was also expressed cytosolically. In yeast,
cytosolic expression of wild-type A&#x003b2;42-GFP, as well as of a comprehensive set of A&#x003b2;
peptide variants (fused to GFP), was not associated with any observable cytotoxicity (<xref
rid="B77" ref-type="bibr">Morell <italic>et&#x000a0;al</italic>., 2011</xref>; <xref rid="B101"
ref-type="bibr">Villar-Pique and Ventura, 2013</xref>). <xref rid="B9" ref-type="bibr">Caine
<italic>et&#x000a0;al</italic>. (2007)</xref> reported a minor reduction (5%) in growth of yeast
cells (at &#x0223c;10 h) expressing cytosolically localized A&#x003b2;42-GFP. In contrast,
substantial toxicity was reported when A&#x003b2; was expressed in the endoplasmic reticulum (<xref
rid="B96" ref-type="bibr">Treusch <italic>et&#x000a0;al</italic>., 2011</xref>; <xref rid="B16"
ref-type="bibr">D'Angelo <italic>et&#x000a0;al.</italic>, 2013</xref>).</p>
</sec>
<sec>
<title>A&#x003b2;42 seeds formation of punctate aggregates of A&#x003b2;40</title>
<p>A&#x003b2; toxicity has been shown to correlate with the presence of fibrils or &#x003b2;-sheet
structures (<xref rid="B43" ref-type="bibr">Howlett <italic>et&#x000a0;al</italic>., 1995</xref>;
<xref rid="B90" ref-type="bibr">Simmons <italic>et&#x000a0;al</italic>., 1994</xref>; <xref
rid="B84" ref-type="bibr">Seilheimer <italic>et&#x000a0;al</italic>., 1997</xref>). However, gaps
remain in understanding the mechanisms by which A&#x003b2; aggregation mediates neuronal death.
A&#x003b2; aggregation proceeds by a multistep, nucleation-dependent process (<xref rid="B46"
ref-type="bibr">Jarrett and Lansbury, 1993</xref>). Formation of nucleation seeds is rate limiting,
and in the absence of preformed seed fibrils, there is a significant lag period for the formation of
A&#x003b2; fibrils, followed by a rapid fibril elongation phase once seed fibrils have been
generated. The lag time for fibril formation can be dramatically shortened by adding preformed
fibril seeds to A&#x003b2; monomer (<xref rid="B46" ref-type="bibr">Jarrett and Lansbury,
1993</xref>). The rate of A&#x003b2; fibril formation is controlled by both fibril seed and monomer
concentrations (<xref rid="B78" ref-type="bibr">Naiki and Nakakuki, 1996</xref>). To examine whether
the more-aggregation-prone AB42-GFP affected fluorescence produced by the less-aggregation-prone
AB40-GFP form, we undertook parallel expression in wild-type cells of A&#x003b2;42 plus
A&#x003b2;40, A&#x003b2;42 plus A&#x003b2;EP, or A&#x003b2;40 plus A&#x003b2;EP.</p>
<p>Coinduction of A&#x003b2;42-GFP and A&#x003b2;40-GFP gave rise to more fluorescent cells
(&#x0223c;22%) than did expression of the A&#x003b2;42-GFP alone (5%) but significantly fewer than
cells expressing A&#x003b2;40-GFP alone (&#x0223c;40%; <xref ref-type="fig" rid="F2">Figure
2</xref>). Cells expressing both A&#x003b2;42-GFP and A&#x003b2;40-GFP exhibited trace cytosolic
fluorescence, with intense large puncta, and in some cells there were elongated structures (<xref
ref-type="fig" rid="F2">Figure 2</xref>). Coinduction of A&#x003b2;42-GFP and A&#x003b2;EP-GFP in
wild-type cells also gave rise to more fluorescent cells (&#x0223c;28%; exhibiting cytosolic
fluorescence with small, intense puncta) compared with those expressing A&#x003b2;42-GFP alone but
significantly fewer than cells expressing A&#x003b2;EP-GFP alone (&#x0223c;70%). Coinduction of
A&#x003b2;40-GFP and A&#x003b2;EP-GFP in wild-type cells gave rise to intense cytosolic fluorescent
cells (&#x0223c;60%) comparable to wild-type cells expressing A&#x003b2;EP alone, and 30% of the
fluorescent cells contained small puncta (<xref ref-type="fig" rid="F2">Figure 2</xref>). The
increased presence of puncta and lower levels of cytosolic fluorescence in wild-type cells
coexpressing either A&#x003b2;42-GFP and A&#x003b2;40-GFP or A&#x003b2;42-GFP and A&#x003b2;EP-GFP
indicated that the more-aggregation-prone A&#x003b2;42-GFP can act as a seed for aggregation.
Preformed A&#x003b2;42-GFP aggregates formed in the cytosol may therefore accelerate nucleation and
act as seeds for further formation of intracellular aggregates and fibrils.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>(A) Fluorescence microscope images of wild-type cells coexpressing A&#x003b2;42-GFP and
A&#x003b2;40-GFP; A&#x003b2;42-GFP and A&#x003b2;EP-GFP; or A&#x003b2;40-GFP and A&#x003b2;EP-GFP.
Wild-type cells expressing these constructs were induced in SC-galactose medium, and fluorescence
was analyzed at OD<sub>600</sub> of 1.5. Bar, 5 &#x003bc;m. (B) Proportion of fluorescent wild-type
cells expressing GFP, A&#x003b2;42-GFP, A&#x003b2;40-GFP, or A&#x003b2;EP-GFP. Nine hundred cells
were counted per sample, and data shown are averages of three independent experiments.
*<italic>p</italic> &#x0003c; 0.01.</p>
</caption>
<graphic xlink:href="2235fig2"/>
</fig>
<p>Together these data highlight the inverse correlation between the relative aggregation propensity
of the A&#x003b2; moiety fused to GFP and the level of fluorescence intensity of the A&#x003b2;-GFP
fusion protein in yeast cells.</p>
</sec>
<sec>
<title>Cellular processes affecting A&#x003b2;42-GFP&#x02013;associated fluorescence</title>
<p>To identify processes affecting intracellular A&#x003b2;42-GFP aggregation, individual homozygous
diploid strains of the genome-wide <italic>S. cerevisiae</italic> deletion library (<xref rid="B105"
ref-type="bibr">Winzeler <italic>et&#x000a0;al</italic>., 1999</xref>) were transformed with the
A&#x003b2;42-GFP construct and screened using fluorescence microscopy to identify mutants exhibiting
increased A&#x003b2;42-GFP&#x02013;associated fluorescence and/or altered localization relative to
wild-type cells. Expression of the A&#x003b2;42-GFP fusion in each strain was induced by growth in
SC galactose medium (&#x02013;Ura), and A&#x003b2;42-GFP&#x02013;associated fluorescence was
analyzed 12&#x02013;18 h postinduction. Rescreening, in duplicate, of mutants that exhibited altered
fluorescence during the primary screen led to identification of 344 mutants that exhibited
fluorescence reproducibly different from that of the wild type. These mutants fell into two broad
sets according to the intensity of fluorescence and/or percentage of fluorescent cells. The first
set of 110 mutants contained those exhibiting strong fluorescence in &#x02265;15% of cells (<xref
ref-type="table" rid="T1">Table 1</xref>). The other 234 mutants exhibited moderate to weak
fluorescence in 5&#x02013;10% of cells (Supplemental Table S3). Of note, 50 of the 110 <italic>S.
cerevisiae</italic> genes in <xref ref-type="table" rid="T1">Table 1</xref> have orthologues in
humans.</p>
<table-wrap id="T1" position="float">
<label>TABLE 1:</label>
<caption>
<p><italic>S. cerevisiae</italic> genes whose deletion led to a strong increase in
A&#x003b2;42-GFP&#x02013;associated fluorescence, together with the respective localization of
fluorescence.</p>
</caption>
<table frame="hsides" rules="groups">
<thead valign="bottom">
<tr>
<th align="left" rowspan="1" colspan="1">Open reading frame/gene name</th>
<th align="left" rowspan="1" colspan="1">A&#x003b2;42-GFP localization pattern</th>
<th align="left" rowspan="1" colspan="1">Respiratory deficiency</th>
<th align="left" rowspan="1" colspan="1">Human orthologue</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left" colspan="4" rowspan="1">Chromatin remodeling/histone exchange</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>CHD1</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1">CHD2</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>HIR1</italic></td>
<td align="left" rowspan="1" colspan="1">Single small punctate</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1">HIRA</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>HTA2</italic></td>
<td align="left" rowspan="1" colspan="1">Single small punctate</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1">H2AFX</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>SWC5</italic></td>
<td align="left" rowspan="1" colspan="1">Single small punctate</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1">CFDP1</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>SWR1</italic></td>
<td align="left" rowspan="1" colspan="1">Multiple puncta</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>VPS71</italic></td>
<td align="left" rowspan="1" colspan="1">Multiple small puncta</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>VPS72</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic with single large punctate</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>YDL041W</italic></td>
<td align="left" rowspan="1" colspan="1">Multiple small puncta</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" colspan="4" rowspan="1">Lipid metabolism/transport</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>CHO2</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic with one or two small puncta</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>DET1</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>INO2</italic></td>
<td align="left" rowspan="1" colspan="1">ER-associated</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>INO4</italic></td>
<td align="left" rowspan="1" colspan="1">Punctate</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>IPK1</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic with single large punctate</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>OPI3</italic></td>
<td align="left" rowspan="1" colspan="1">ER-associated</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1">PEMT</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>PDX3</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic with punctate and nuclear</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">PNPO</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>PSD1</italic></td>
<td align="left" rowspan="1" colspan="1">ER-associated</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1">PISD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>SCS2</italic></td>
<td align="left" rowspan="1" colspan="1">Single large punctate</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1">VAPA</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>UME6</italic></td>
<td align="left" rowspan="1" colspan="1">Single small punctate</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>YER119C-A</italic></td>
<td align="left" rowspan="1" colspan="1">Single small punctate</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" colspan="4" rowspan="1">Mitochondrial functions</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>ACO1</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic with one or two small puncta</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">ACO2</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>ACO</italic>2</td>
<td align="left" rowspan="1" colspan="1">Cytosolic</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>AIM4</italic></td>
<td align="left" rowspan="1" colspan="1">Single small punctate</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>ATP11</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic with one or two puncta</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">ATPAF1</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>CBP3</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic with puncta</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">UQCC</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>CIT1</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic with one or two small puncta</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>CIT3</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic with one or two small puncta</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>COX16</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>COX20</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>CYM1</italic></td>
<td align="left" rowspan="1" colspan="1">Single small punctate</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1">PITRM1</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>FUM1</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic with puncta</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">FH</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>HAP2</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">NFYA</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>HAP3</italic></td>
<td align="left" rowspan="1" colspan="1">Single small punctate</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">NFYB</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>IDH1</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic with small puncta</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">IDH3B</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>IDH2</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic with small puncta</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">IDH3A</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>IDP1</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic with small puncta</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1">IDH1</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>KGD1</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">OGDH</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>KGD2</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">DLST</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>LPD1</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">DLD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>LSC1</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">SUCLG1</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>LSC2</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>MDH1</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1">MDH2</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>MIC14</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>MRPL35</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">MRPL35</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>MRPL7</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic with small puncta</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>PET112</italic></td>
<td align="left" rowspan="1" colspan="1">Single small punctate</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">PET112L</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>PET117</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>PYC1</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic with small puncta</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1">PC</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>PYC2</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1">PC</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>RIM1</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>RRG8</italic></td>
<td align="left" rowspan="1" colspan="1">Large punctate and nuclear-diffused</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>RSM18</italic></td>
<td align="left" rowspan="1" colspan="1">Single small punctate</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>RSM7</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>SDH1</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1">SDHA</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>SDH2</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">SDHB</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>SDH4</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic with puncta</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">SDHD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>STF2</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic with single large punctate</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>TUF1</italic></td>
<td align="left" rowspan="1" colspan="1">Single small punctate</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">TUFM</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>YDR230W</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" colspan="4" rowspan="1">Gene expression/regulation</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>CTK1</italic></td>
<td align="left" rowspan="1" colspan="1">One or two small puncta</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>DEG1</italic></td>
<td align="left" rowspan="1" colspan="1">Single large punctate</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1">PUS3</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>ELC1</italic></td>
<td align="left" rowspan="1" colspan="1">Single small punctate</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>GAT1</italic></td>
<td align="left" rowspan="1" colspan="1">Single small punctate</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>GDT1</italic></td>
<td align="left" rowspan="1" colspan="1">Single small punctate</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">TMEM165</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>HFI1</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>LSM7</italic></td>
<td align="left" rowspan="1" colspan="1">Multiple small puncta</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">LSM7</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>MED1</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic with one or two small puncta</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1">MED1</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>MOT2</italic></td>
<td align="left" rowspan="1" colspan="1">Single small punctate</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>NCL1</italic></td>
<td align="left" rowspan="1" colspan="1">Single small punctate</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1">NSUN2</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>SNT309</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic with one or two small puncta</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>SRB8</italic></td>
<td align="left" rowspan="1" colspan="1">One or two small puncta</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">MED12L</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>SSN2</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic with single large punctate</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1">MED13L</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>SSN3</italic></td>
<td align="left" rowspan="1" colspan="1">Multiple small puncta</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">CDK8</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>SYC1</italic></td>
<td align="left" rowspan="1" colspan="1">Single small punctate</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>TIF4631</italic></td>
<td align="left" rowspan="1" colspan="1">Multiple small puncta</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">EIF4G1</td>
</tr>
<tr>
<td align="left" colspan="4" rowspan="1">Mitotic cell cycle</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>CTS1</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>DCC1</italic></td>
<td align="left" rowspan="1" colspan="1">Single small punctate</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">DSCC1</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>POG1</italic></td>
<td align="left" rowspan="1" colspan="1">Single small punctate</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>SWI4</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic with single small punctate</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" colspan="4" rowspan="1">Methionine metabolism</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>MET16</italic></td>
<td align="left" rowspan="1" colspan="1">Single small punctate</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>MET8</italic></td>
<td align="left" rowspan="1" colspan="1">Single small punctate</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>MXR1</italic></td>
<td align="left" rowspan="1" colspan="1">Single small punctate</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1">MSRA</td>
</tr>
<tr>
<td align="left" colspan="4" rowspan="1">Purine metabolism</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>ADE12</italic></td>
<td align="left" rowspan="1" colspan="1">Single small punctate</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1">ADSSL1</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>ADK1</italic></td>
<td align="left" rowspan="1" colspan="1">Single small punctate</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1">AK2</td>
</tr>
<tr>
<td align="left" colspan="4" rowspan="1">Spindle pole body</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>BFA1</italic></td>
<td align="left" rowspan="1" colspan="1">Single small punctate</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>BIM1</italic></td>
<td align="left" rowspan="1" colspan="1">Single small punctate</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1">MAPRE1</td>
</tr>
<tr>
<td align="left" colspan="4" rowspan="1">Ubiquitin/proteasome</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>SAN1</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>SHP1</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic with puncta</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">NSFL1C</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>UBR1</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosol with large punctate</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1">UBR1</td>
</tr>
<tr>
<td align="left" colspan="4" rowspan="1">Bud-site selection</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>BUD23</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic with punctate</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">WBSCR22</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>BUD31</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic with puncta</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">BUD31</td>
</tr>
<tr>
<td align="left" colspan="4" rowspan="1">MAP kinase activity</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>PBS2</italic></td>
<td align="left" rowspan="1" colspan="1">Single small punctate</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1">MAP2K4</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>SLG1</italic></td>
<td align="left" rowspan="1" colspan="1">Single small punctate</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>SOK1</italic></td>
<td align="left" rowspan="1" colspan="1">Multiple small puncta</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" colspan="4" rowspan="1">Others/unknown</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>APJ1</italic></td>
<td align="left" rowspan="1" colspan="1">Single small punctate</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>ASM4</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic with large punctate</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>EMI2</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic with small puncta</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>GTT3</italic></td>
<td align="left" rowspan="1" colspan="1">Single small punctate</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>ICE2</italic></td>
<td align="left" rowspan="1" colspan="1">ER-associated</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>ICY2</italic></td>
<td align="left" rowspan="1" colspan="1">Single small punctate</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>PAU11</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>PHM6</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic puncta</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>RAD61</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic punctate</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>RIB1</italic></td>
<td align="left" rowspan="1" colspan="1">Multiple puncta</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>RKM4</italic></td>
<td align="left" rowspan="1" colspan="1">Single small punctate</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>SNX41</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic with one or two small puncta</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>YDL242W</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>YDR015C</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>YEL008W</italic></td>
<td align="left" rowspan="1" colspan="1">Single small punctate</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>YIM2</italic></td>
<td align="left" rowspan="1" colspan="1">Cytosolic</td>
<td align="left" rowspan="1" colspan="1">No</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>YOR364W</italic></td>
<td align="left" rowspan="1" colspan="1">Single small Punctate</td>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
</tbody>
</table>
</table-wrap>
<p>Because many <italic>S. cerevisiae</italic> genes have human orthologues, identification of these
may help to identify cellular processes in humans that play a role in A&#x003b2;42 aggregation. Of
the 110 <italic>S. cerevisiae</italic> genes in <xref ref-type="table" rid="T1">Table 1</xref>, 50
have human orthologues identified using the National Center for Biotechnology Information database,
HomoloGene. These genes may provide a point for more targeted studies in mammalian AD model
systems.</p>
<p>Five distinct A&#x003b2;42-GFP localization patterns were observed among the 110 mutants
identified by the genome-wide screen (<xref ref-type="fig" rid="F3">Figure 3</xref>): single
punctate (29%), multiple puncta (9%), cytosolic-diffuse (22%), distinct arc-shaped (5%), and a
combination of punctate and cytosolic-diffuse fluorescence (35%). The percentages are based on the
number of mutants in each group. An example of each of these localization patterns is given in <xref
ref-type="fig" rid="F3">Figure 3</xref>.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Fluorescence microscope images of representative mutants exhibiting various A&#x003b2;42-GFP
localization patterns. Strains expressing A&#x003b2;42EGFP were induced in SC-galactose medium, and
A&#x003b2;42-GFP&#x02013;associated fluorescence was analyzed between 12 and 18 h postinduction
(OD<sub>600</sub> of &#x0223c;1.5). The A&#x003b2;42-GFP&#x02013;associated localization patterns
were classified as (A) fluorescent punctate, (B) multiple fluorescent puncta, (C) cytosolic-diffuse
fluorescence, (D) arc-shaped perinuclear fluorescence, and (E) combination of puncta and cytosolic
fluorescence. Arrows indicate the specific type of localization in each of the mutants. Bar, 5
&#x003bc;m. (F) Graphic representation of cellular processes identified affecting
A&#x003b2;42-GFP&#x02013;associated fluorescence in <italic>S</italic>. <italic>cerevisiae</italic>.
Percentages reflect the number of mutants identified in a particular cellular process relative to
the total number of mutants identified by the genome-wide screen.</p>
</caption>
<graphic xlink:href="2235fig3"/>
</fig>
<p>Functional categories overrepresented in the group of 110 genes indicated the main cellular
processes likely to affect intracellular A&#x003b2;42 aggregation. Manual inspection of the list
identified processes including phospholipid metabolism, mitochondrial function, and chromatin
remodeling. In addition, histone exchange (<italic>p</italic> = 2.12 &#x000d7;
10<sup>&#x02212;5</sup>), DNA-dependent transcription (<italic>p</italic> = 0.0009), chromatin
remodeling (<italic>p</italic> = 0.009) and modification (<italic>p</italic> = 0.001), and
tricarboxylic acid (TCA) cycle (<italic>p</italic> &#x0003e; 1 &#x000d7; 10<sup>&#x02212;14</sup>)
functions were significantly overrepresented using SGD FunCat GO Term Finder. Analysis using Munich
Information Centre for Protein Sequences (MIPS) FunCatDB yielded a very similar set of functional
categories but also identified phosphatidylcholine (PC) biosynthesis/phospholipid metabolism
(<italic>p</italic> = 0.001), regulation of lipid, fatty acid, and isoprenoid metabolism
(<italic>p</italic> = 0.008), sulfate assimilation (<italic>p</italic> = 0.007), and transcriptional
control (<italic>p</italic> = 0.0005) to be overrepresented (<xref ref-type="fig" rid="F3">Figure
3</xref>).</p>
<p>Of the 110 mutants identified in the genome-wide screen, 35% (39 mutants from 110) were annotated
in the <italic>Saccharomyces</italic> Genome Database as exhibiting disrupted mitochondrial
respiratory function. Analysis of process ontology identified acetyl-CoA catabolism and enzymes of
the TCA cycle, including isocitrate dehydrogenase (Idp1p), &#x003b1;-ketoglutarate dehydrogenase
(Kgd2p), succinate dehydrogenase (Sdh4p), aconitase (Aco1p), and fumarase (Fum1p) to be
significantly overrepresented (<italic>p</italic> = 7.71 &#x000d7; 10<sup>&#x02212;22</sup>).
Fluorescent A&#x003b2;42-GFP in TCA cycle mutants was cytosolic-diffuse, or cytosolic-diffuse with
single to multiple small puncta (<xref ref-type="fig" rid="F4">Figure 4</xref>), which did not
appear to occur in a distinct structure in the cell. Mitochondrial mutants that had strongly
affected A&#x003b2;42-GFP&#x02013;associated fluorescence were mainly defective in metabolism of
pyruvate to oxaloacetate and disruption of the TCA cycle. It was previously demonstrated that 341
nuclear genes affect respiratory growth capacity and/or mitochondrial morphology, including numerous
genes encoding subunits of the mitochondrial electron transport chain complexes and factors required
for their assembly, enzymes of the TCA cycle, mitochondrial ribosome function and maintenance, and
inheritance of the mitochondrial genome (<xref rid="B15" ref-type="bibr">Dimmer
<italic>et&#x000a0;al</italic>., 2002</xref>). In the event that some mutants may have been missed
in the initial screen, a comprehensive rescreening of representative mutants affected in
mitochondrial functions was undertaken and A&#x003b2;42-GFP&#x02013;associated fluorescence
reassessed in each strain. These analyses not only validated the 39 mitochondrial mutants identified
in the initial screen as having strongly affected A&#x003b2;42-GFP&#x02013;associated fluorescence,
but they also confirmed that loss of many other genes involved in mitochondrial functions, including
respiratory energy production, mitochondrial ribosome function, and mitochondrial genome
maintenance, did not affect A&#x003b2;42-GFP fluorescence in the same manner. Of those &#x0223c;30
non-TCA cycle mutants that were affected in A&#x003b2;42-GFP fluorescence, the effect was
comparatively weak in terms of fluorescence intensity and the proportion of affected cells in a
given population (Supplemental Table S3).</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Fluorescence microscope images of mutants expressing A&#x003b2;42-GFP induced in galactose
medium, and analysis of A&#x003b2;42-GFP&#x02013;associated fluorescence (OD<sub>600</sub> of
&#x0223c;1.5). (A) <italic>&#x00394;aco1</italic>, (B) <italic>&#x00394;fum1</italic>, (C)
<italic>&#x00394;idp1</italic>, (D) <italic>&#x00394;kgd2</italic>, and (E)
<italic>&#x00394;sdh4</italic> predominantly exhibit cytosolic-diffuse
A&#x003b2;42-GFP&#x02013;associated fluorescence, with some mutants exhibiting fluorescent puncta.
Phospholipid mutants (F) <italic>&#x00394;opi3</italic>, (G) <italic>&#x00394;psd1</italic>, (H)
<italic>&#x00394;cho2</italic>, and (I) <italic>&#x00394;ino2</italic>. A&#x003b2;42-GFP-associated
fluorescence in wild-type cells overexpressing (J) <italic>INM1</italic> cytosolic diffuse, (K)
<italic>INM2</italic> cytosolic diffuse, or (L) <italic>CDS1</italic> exhibiting perinuclear
A&#x003b2;42-GFP localization. Arrows point to a distinct localization pattern. Bar, 5
&#x003bc;m</p>
</caption>
<graphic xlink:href="2235fig4"/>
</fig>
<p>The mitochondrial genome (mtDNA) of <italic>S. cerevisiae</italic> encodes eight proteins that
are essential for oxidative phosphorylation (<xref rid="B97" ref-type="bibr">Tzagoloff and
Dieckmann, 1990</xref>), and deletion of mtDNA leads to respiratory incompetence due to disruption
of the mitochondrial electron transport chain. <italic>S. cerevisiae</italic> is a facultative
aerobe, and respiratory-incompetent cells can grow on carbon sources such as glucose or galactose.
To further examine whether the disruption of respiratory function per se affected A&#x003b2;42-GFP
fluorescence, we grew rho-zero (rho<sup>0</sup>) cells lacking mtDNA derived from wild-type (BY4743)
<italic>S. cerevisiae</italic> in SC galactose (inducing) medium and analyzed the effect on
A&#x003b2;42-GFP. Respiratory-incompetent rho<sup>0</sup> cells yielded similar trace levels of
A&#x003b2;42-GFP fluorescence (&#x0223c;5%), comparable to wild-type grande cells, indicating that
loss of respiratory function per se does not affect A&#x003b2;42-GFP&#x02013;associated
fluorescence.</p>
<p>Many mutants affected in mitochondrial function, including those affected in operation of the TCA
cycle, exhibit a reduced growth rate (<xref rid="B26" ref-type="bibr">Giaever
<italic>et&#x000a0;al</italic>., 2002</xref>; <xref rid="B72" ref-type="bibr">McCammon
<italic>et&#x000a0;al</italic>., 2003</xref>), and this may have indirectly influenced
A&#x003b2;42-GFP fluorescence in the present screen. However, this explanation is unlikely, since
there was complete lack of correlation between the genes identified in the present study and
&#x0223c;720 yeast genes whose deletion was previously shown to cause slow growth (<xref rid="B26"
ref-type="bibr">Giaever <italic>et&#x000a0;al</italic>., 2002</xref>; <xref rid="B40"
ref-type="bibr">Hillenmeyer <italic>et&#x000a0;al</italic>., 2008</xref>), and, more broadly, the
&#x0223c;340 genes identified previously that are involved in mitochondrial morphology and/or
respiration. Mitochondrial dysfunction in rho<sup>0</sup> cells has been shown to promote increased
Gal4-dependent transcription (<xref rid="B47" ref-type="bibr">Jelicic
<italic>et&#x000a0;al</italic>., 2005</xref>). Loss of mitochondrial function was not a primary
cause of increased A&#x003b2;42-GFP fluorescence in the mitochondrial mutants, since rho<sup>0</sup>
cells exhibited the same A&#x003b2;42-GFP fluorescence as the wild-type parent. These data support
the hypothesis that loss of distinct mitochondrial functions, including those involved in TCA cycle
function, metabolism of pyruvate to oxaloacetate, and cytochrome <italic>c</italic> oxidase
activity, leads to increased A&#x003b2;42-GFP&#x02013;associated fluorescence and thus influences
A&#x003b2; aggregation.</p>
<p>Disruption of genes involved in the TCA cycle leads to altered expression of &#x0223c;400 genes,
including decreased expression of genes involved in glucose uptake (<italic>HXT7, HXT6</italic>),
glycolysis (<italic>PFK26, FBP26</italic>), and glycogen/trehalose production (<italic>GDB1, GPH1,
GSY1, TPS1, TSL1</italic>), and, conversely, induction of genes involved in inositol or
phosphatidylcholine biosynthesis biosynthesis (<italic>INO1</italic>, <italic>OPI3</italic>; <xref
rid="B72" ref-type="bibr">McCammon <italic>et&#x000a0;al</italic>., 2003</xref>). Induction of
<italic>INO1</italic> and <italic>OPI3</italic> does not occur in rho<sup>0</sup> cells (<xref
rid="B19" ref-type="bibr">Epstein <italic>et&#x000a0;al</italic>., 2001</xref>; <xref rid="B95"
ref-type="bibr">Traven et a1., 2001</xref>). This raised the possibility that increased inositol
synthesis may lead to increased A&#x003b2;42-GFP fluorescence. To examine this hypothesis more
directly, we assessed the effect on A&#x003b2;42-GFP fluorescence in wild-type BG1805 cells grown to
exponential phase (SC galactose &#x02013;URA&#x02013;HIS) of overexpressing genes encoding Ino1p
(inositol-3-phosphate synthetase) or Inm1p or Inm2p (inositol monophosphatase), which perform
subsequent steps in inositol biosynthesis. Strikingly, overexpression of either
<italic>INM1</italic> or <italic>INM2</italic> led to intense diffuse fluorescence in &#x0223c;18%
of cells compared with the empty vector control and cells overexpressing <italic>INO1</italic>, in
which only trace fluorescence was observed (<xref ref-type="fig" rid="F4">Figure 4</xref>). Although
these data do not establish a direct causal link between increased A&#x003b2;42-GFP fluorescence in
mutants disrupted in TCA function and altered inositol synthesis, it is worth noting that both
situations led to the appearance of intense diffuse A&#x003b2;42-GFP fluorescence in cells. The
broader implications of these data are addressed further in the <italic>Discussion</italic>.</p>
</sec>
<sec>
<title>Phospholipid homeostasis plays an important role in intracellular aggregation of
A&#x003b2;42-GFP</title>
<p>Of the A&#x003b2;42-GFP localization patterns identified, the arc-shaped fluorescence
localization in mutants affected in phospholipid homeostasis was distinctive, and these mutants were
selected for further investigation. Five deletion mutants expressing A&#x003b2;42-GFP exhibited
structured arc-shaped A&#x003b2;42-GFP fluorescence (<xref ref-type="fig" rid="F4">Figure 4</xref>).
Of the five genes involved, three encode consecutive steps in the conversion of phosphatidylserine
to phosphatidylcholine (phosphatidylserine decarboxylase, <italic>PSD1</italic>; and
phosphatidylethanolamine methyltransferases, <italic>CHO2</italic> and <italic>OPI3</italic>) and
two (<italic>INO2</italic> and <italic>INO4</italic>) encode a heterodimeric transcriptional
regulator of phospholipid and inositol biosynthesis (<xref rid="B3" ref-type="bibr">Ambroziak and
Henry, 1994</xref>). From <xref ref-type="fig" rid="F5">Figure 5</xref>, A&#x003b2;42-GFP or
A&#x003b2;40-GFP were localized in a perinuclear location in the &#x00394;<italic>opi3</italic>
mutant. These data indicate that the perinuclear localization of A&#x003b2;42-GFP and
A&#x003b2;40-GFP did not depend on the last two residues of the A&#x003b2; moiety in the former.
High-resolution confocal microscopy indicated that in &#x00394;<italic>opi3</italic> cells the
perinuclear fluorescence consisted of numerous intense puncta localized around the nucleus (<xref
ref-type="fig" rid="F5">Figure 5</xref>). The elongated cell morphology observed with the
&#x00394;<italic>opi3</italic> mutant was not due to induction of A&#x003b2;GFP fusion proteins,
since it was also observed in otherwise genetically identical cells expressing the empty vector
control (pUG35GAL1; see Supplemental Figure S1).</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>A&#x003b2;-GFP localization in the &#x00394;<italic>opi3</italic> mutant. (A)
<italic>&#x00394;opi3</italic> cells expressing A&#x003b2;42-GFP or A&#x003b2;40-GFP (green) were
grown in galactose medium, and fluorescence was analyzed. Cells were costained with DAPI (blue) to
visualize the nucleus, indicating the perinuclear localization of A&#x003b2;42-GFP or
A&#x003b2;40-GFP in &#x00394;<italic>opi3</italic> cells. (B) Confocal microscopic image of a
<italic>&#x00394;opi3</italic> cell expressing A&#x003b2;42-GFP (green) stained with DAPI (blue).
Bar, 5 &#x003bc;m. (C) Western blot analysis, using the 6E10 antibody, of subcellular fractions of
the ER and mitochondria from wild-type and <italic>&#x00394;opi3</italic> cells expressing
A&#x003b2;42-GFP. A&#x003b2;42-GFP band, &#x0223c;31 kDa. Antibodies against Por1p and Wbp1p were
used as controls to validate lack of cross-contamination between mitochondria and ER fractions,
respectively. Dotted lines delineate individual lanes on gels.</p>
</caption>
<graphic xlink:href="2235fig5"/>
</fig>
<p>To investigate more precisely the localization of the fluorescent A&#x003b2;42-GFP in the
&#x00394;<italic>opi3</italic> cells, wild-type and &#x00394;<italic>opi3</italic> cells expressing
the A&#x003b2;42-GFP fusion construct were grown to exponential phase, and subcellular fractionation
of endoplasmic reticulum (ER) and mitochondria was performed. A&#x003b2;42-GFP was detected via
Western blot using the 6E10 antibody. In wild-type cells, a &#x0223c;31-kDa A&#x003b2;42-GFP band
was mainly observed in the mitochondrial fraction, with a very faint band also visible in the ER
fraction (<xref ref-type="fig" rid="F5">Figure 5</xref>). In contrast,
&#x00394;<italic>opi3</italic> cells expressing A&#x003b2;42-GFP exhibited intense &#x0223c;31-kDa
bands corresponding to A&#x003b2;42-GFP in both the ER and mitochondrial fractions. The
A&#x003b2;42-GFP identified in the mitochondrial fraction by cell fractionation and immunoblotting
was therefore nonfluorescent aggregated A&#x003b2;42-GFP, since A&#x003b2;42-GFP&#x02013;associated
fluorescence was not observed in the mitochondria in whole cells via microscopic analysis. Owing to
the appearance of an intense band of A&#x003b2;42-GFP in the mitochondrial fraction in both the wild
type and the &#x00394;<italic>opi3</italic> mutant, the possibility that aggregated A&#x003b2;42-GFP
may have simply cosedimented with the mitochondrial fraction cannot be ruled out. Taken together
with the data from Western blotting, which would detect both fluorescent and aggregated
nonfluorescent A&#x003b2;42-GFP, these data support the proposal that fluorescent A&#x003b2;42-GFP
in &#x00394;<italic>opi3</italic> cells may be localized to the ER/ER membrane. Because
nonaggregated/soluble A&#x003b2;-GFP correlated with fluorescence intensity (<xref ref-type="fig"
rid="F1">Figure 1</xref>), these data also support the proposal that it was the soluble form of
A&#x003b2;42-GFP that had interacted with the ER/ER membrane. These data strongly implicate
phospholipid metabolism/homeostasis as an effector of A&#x003b2;42 aggregation. Given the role of
phospholipids as structural components of cell membranes, disruption of phospholipid
homeostasis&#x02014;for example, as in &#x00394;<italic>opi3</italic> cells, influences the
interaction of &#x0201c;soluble&#x0201d; A&#x003b2;42 (and probably A&#x003b2;40) with the ER
membrane, influencing A&#x003b2; aggregation. These data are of particular interest, given the
localization of many steps of phospholipid synthesis to the ER.</p>
<p>An alternative route of PC synthesis, via the Kennedy salvage pathway, depends on the
availability of precursor molecules, including ethanolamine (EA), monomethylethanolamine,
dimethylethanolamine (DMEA), or choline (<xref rid="B91" ref-type="bibr">Summers
<italic>et&#x000a0;al</italic>., 1988</xref>; <xref rid="B73" ref-type="bibr">McGraw and Henry,
1989</xref>). Because the growth medium used in mutant screening did not contain any of these
substrates, it is likely that the membranes of &#x00394;<italic>psd1</italic>,
&#x00394;<italic>opi3</italic> mutants were depleted in PC and/or additional phospholipids and that
this was associated with altered A&#x003b2;42-GFP&#x02013;associated fluorescence. To test this,
&#x00394;<italic>opi3</italic> cells expressing A&#x003b2;42-GFP or GFP alone were cultured in media
supplemented with 1 mM EA, DMEA, or choline. Media supplementation with 1 mM DMEA or choline (<xref
ref-type="fig" rid="F6">Figure 6</xref>) resulted in reversal to a wild-type phenotype (<xref
ref-type="fig" rid="F6">Figures 6</xref> and <xref ref-type="fig" rid="F1">1</xref>) for
&#x00394;<italic>opi3</italic> cells, with a comparable level of fluorescence to the wild-type
strain. In contrast, treatment of &#x00394;<italic>opi3</italic> cells with EA did not lead to
altered fluorescence relative to untreated cells. This is consistent with the capacity of Opi3p to
methylate either phosphatidyldimethylethanolamine or phosphatidylmonomethylethanolamine but not
phosphatidylethanolamine, leading to PC formation. Treatment of cells expressing GFP alone in a
comparable manner did not lead to any difference in fluorescence. The perinuclear localization of
A&#x003b2;42-GFP fluorescence in &#x00394;<italic>opi3</italic> cells therefore appears to be
related to their capacity to maintain PC homeostasis.</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Fluorescence microscopic images of <italic>&#x00394;opi3</italic> cells expressing GFP or
A&#x003b2;42-GFP grown in galactose (induction) medium either lacking or supplemented with 1 mM
ethanolamine (EA), dimethylethanolamine (DMEA), or choline. Cells were analyzed for fluorescence in
exponential phase (OD<sub>600</sub> of &#x0223c;1.5). Bar, 5 &#x003bc;m.</p>
</caption>
<graphic xlink:href="2235fig6"/>
</fig>
</sec>
<sec>
<title>Overexpression of <italic>CDS1</italic>, encoding cytidine diphosphate&#x02013;diacylglycerol
synthase, alters A&#x003b2;42-GFP&#x02013;associated fluorescence</title>
<p>To obtain further insight into the link between altered phospholipid homeostasis and
A&#x003b2;42-GFP fluorescence, we assessed the effect of overexpressing genes involved in
phospholipid metabolism on A&#x003b2;42-GFP. Wild-type cells were transformed with the plasmids
carrying one of each of numerous genes involved in lipid metabolism (listed in Supplemental Table
S4) and the cells examined to identify those exhibiting increased
A&#x003b2;42-GFP&#x02013;associated fluorescence and/or altered fluorescence morphology. Cells with
the plasmids that encode proteins involved in lipid synthesis/regulation were cotransformed with the
pA&#x003b2;42-GFP construct in corresponding deletion mutant strains, as well as in wild-type cells.
Expression of the A&#x003b2;42-GFP fusion protein and the lipid-related gene in each strain was
induced by growth in galactose medium, and A&#x003b2;42-GFP&#x02013;associated fluorescence was
analyzed 12&#x02013;18 h postinduction.</p>
<p>Cells overexpressing <italic>CDS1</italic> exhibited ordered localization of intensely
fluorescent puncta of A&#x003b2;42-GFP in a perinuclear arrangement analogous to that seen in the
&#x00394;<italic>psd1</italic>, &#x00394;<italic>cho2</italic>, and &#x00394;<italic>opi3</italic>
mutants (<xref ref-type="fig" rid="F4">Figure 4</xref>). <italic>CDS1</italic> encodes CDP-DAG
synthase, which catalyzes CDP-DAG&#x02013;dependent synthesis of phospholipids from phosphatidic
acid (<xref rid="B42" ref-type="bibr">Homann <italic>et&#x000a0;al</italic>., 1985</xref>). These
data further support that A&#x003b2;42-GFP aggregation is strongly influenced by altered
phospholipid homeostasis in <italic>S. cerevisiae</italic> cells.</p>
</sec>
</sec>
<sec sec-type="discussion">
<title>DISCUSSION</title>
<p>The finding that fluorescence of an A&#x003b2;-GFP fusion protein is inversely proportional to
its propensity to aggregate in <italic>E. coli</italic> (<xref rid="B53" ref-type="bibr">Kim and
Hecht, 2005</xref>, <xref rid="B54" ref-type="bibr">2008</xref>) provides an elegant and adaptable
approach for exploring the intracellular properties of A&#x003b2;. The present study demonstrates
that when expressed in the cytosol of the yeast <italic>S. cerevisiae</italic>, the inverse
relationship between A&#x003b2;-GFP fluorescence and aggregation potential is preserved. This system
forms the foundation of a genetically tractable eukaryotic platform for identifying processes that
affect intracellular A&#x003b2; aggregation, an important feature in the pathology of Alzheimer's
disease. We transformed an A&#x003b2;42-GFP expression plasmid into the entire <italic>S.
cerevisiae</italic> genome deletion mutant collection and examined individual mutants for changes in
A&#x003b2;42-GFP fluorescence. Conversely, we also overexpressed a targeted panel of genes in
wild-type cells expressing A&#x003b2;42-GFP and examined the effect on fluorescence.</p>
<p>This approach identified 110 deletion mutants exhibiting strong
A&#x003b2;42-GFP&#x02013;associated fluorescence and 234 deletion mutants that exhibited weak
fluorescence. After clustering mutants into broad functional categories, three emerged as being
significantly overrepresented: mitochondrial function, phospholipid metabolism, and
transcriptional/translational regulation. Overexpression of the genes <italic>CDS1</italic>,
<italic>INM1</italic>, and <italic>INM2</italic> significantly increased fluorescence in
A&#x003b2;42-GFP&#x02013;expressing wild-type cells, additionally implicating inositol biosynthesis
as a fourth functional class.</p>
<p>These functional categories parallel some of those affected in Alzheimer's disease patients, and
several genes identified in our screen have human homologues that have been found to be directly
related to A&#x003b2; and Alzheimer's pathology. Mutants affected in mitochondrial function and
tricarboxylic acid cycle function exhibited the highest changes in fluorescence identified in the
screen (both intensity and proportion of cells), mirroring the long association of mitochondrial
dysfunction with Alzheimer's pathology (<xref rid="B14" ref-type="bibr">de Leon
<italic>et&#x000a0;al</italic>., 1983</xref>; <xref rid="B4" ref-type="bibr">Atamna and Frey,
2007</xref>). Human homologues of the yeast TCA cycle screen hits &#x003b1;-ketoglutarate
dehydrogenase (<italic>KGD2</italic>) and isocitrate dehydrogenase (<italic>IDP1</italic>) show
reduced activity in AD patient brains, with the extent of reduction correlating closely with
decreased mental performance (<xref rid="B28" ref-type="bibr">Gibson
<italic>et&#x000a0;al</italic>., 2000</xref>, <xref rid="B27" ref-type="bibr">2005</xref>; <xref
rid="B57" ref-type="bibr">Ko <italic>et&#x000a0;al</italic>., 2001</xref>; <xref rid="B8"
ref-type="bibr">Bubber <italic>et&#x000a0;al</italic>., 2005</xref>; <xref rid="B11" ref-type="bibr"
>Chaturvedi and Beal, 2013</xref>). Decreased activity of &#x003b1;-ketoglutarate dehydrogenase
leads to sensitivity to oxidative damage, which is strongly associated with AD (<xref rid="B88"
ref-type="bibr">Shi <italic>et&#x000a0;al</italic>., 2011</xref>). Given that rho<sup>0</sup>
respiratory-deficient cells and a range of other mitochondrial mutants displayed wild-type
A&#x003b2;42-GFP fluorescence, altered A&#x003b2; aggregation appears to be specifically linked to
TCA cycle and oxaloacetate-to-pyruvate defects.</p>
<p>One potential explanation for this may relate to inositol metabolism. In yeast, disruption of TCA
function increases expression of inositol-3-phosphate synthase (encoded by <italic>INO1</italic>), a
key enzyme in inositol synthesis (<xref rid="B72" ref-type="bibr">McCammon
<italic>et&#x000a0;al</italic>., 2003</xref>). We demonstrated that overexpression of either of the
<italic>myo</italic>-inositol biosynthetic genes <italic>INM1</italic> or <italic>INM2</italic> led
to the appearance of similar intense, diffuse A&#x003b2;42-GFP fluorescence as observed in the TCA
cycle mutants, suggesting a link between inositol metabolism, the TCA cycle, and A&#x003b2;
aggregation. In human brain, <italic>myo</italic>-inositol is the most abundant stereoisomer (<xref
rid="B39" ref-type="bibr">Haris <italic>et&#x000a0;al</italic>., 2011</xref>) and forms small stable
micelles with the A&#x003b2; peptide (<xref rid="B75" ref-type="bibr">McLaurin
<italic>et&#x000a0;al</italic>., 1998</xref>). Amyloid fibril formation is inhibited by
<italic>myo</italic>-inositol (<xref rid="B24" ref-type="bibr">Gellermann
<italic>et&#x000a0;al</italic>., 2007</xref>), and complexation of A&#x003b2; with inositol protects
neuronal cultures from A&#x003b2; toxicity (<xref rid="B76" ref-type="bibr">McLaurin
<italic>et&#x000a0;al</italic>., 2000</xref>). Similarly, the <italic>scyllo</italic>-inositol
stereoisomer inhibits amyloid formation (<xref rid="B63" ref-type="bibr">Li
<italic>et&#x000a0;al</italic>., 2012</xref>; <xref rid="B71" ref-type="bibr">Ma
<italic>et&#x000a0;al</italic>., 2012</xref>), and treatment of animal AD models with
<italic>scyllo</italic>-inositol reduces plaque formation and improves memory performance and
hippocampal synaptic plasticity (<xref rid="B74" ref-type="bibr">McLaurin
<italic>et&#x000a0;al</italic>., 2006</xref>; <xref rid="B5" ref-type="bibr">Aytan
<italic>et&#x000a0;al</italic>., 2013</xref>). Of note, the activity of the human
<italic>myo</italic>-inositol monophosphatase homologue of the yeast
<italic>INM1</italic>/<italic>INM2</italic> genes identified in this study is raised in the brains
of AD patients, possibly reflecting a compensatory change to altered phospholipid metabolism (<xref
rid="B87" ref-type="bibr">Shimohama <italic>et&#x000a0;al</italic>., 1998</xref>). Furthermore,
<italic>scyllo</italic>-inositol was previously identified as an inhibitor of A&#x003b2;
oligomerization in yeast (<xref rid="B82" ref-type="bibr">Park <italic>et&#x000a0;al</italic>.,
2011</xref>). Our results, together with those previously reported, suggest that inositol metabolism
modulates the aggregation of the A&#x003b2; peptide and offer a potential link to the increased
A&#x003b2;42-GFP fluorescence observed in TCA cycle mutants. Increased inositol levels resulting in
formation of soluble inositol/A&#x003b2;42-GFP micelles and inhibition of A&#x003b2;42-GFP
oligomerization offers a potential mechanistic explanation for the significant fluorescence observed
in <italic>INM1</italic>/<italic>INM2</italic>-overexpressing cells.</p>
<p>In addition to alteration of inositol production, TCA cycle dysfunction would also affect
NAD<sup>+</sup>/NADH homeostasis. NAD<sup>+</sup> availability may modulate sirtuin-2 activity,
leading to altered A&#x003b2; deposition, tubulin deacetylation, and potentiation of tau
hyperphosphorylation (<xref rid="B89" ref-type="bibr">Silva <italic>et&#x000a0;al</italic>.,
2011</xref>). Given the role of sirtuins in chromatin remodeling, it is interesting to note that our
screen identified numerous mutants affected in similar functions, particularly those affecting the
Swr1 chromatin remodeling complex, suggesting the existence of a potential link between A&#x003b2;
aggregation, TCA metabolite levels, and chromatin dynamics.</p>
<p>Several mutants affecting phospholipid synthesis exhibited increased A&#x003b2;42-GFP
fluorescence in our screen. There is strong evidence of perturbed phospholipid metabolism in AD
patients (<xref rid="B44" ref-type="bibr">Hung <italic>et&#x000a0;al</italic>., 2008</xref>; <xref
rid="B22" ref-type="bibr">Frisardi <italic>et&#x000a0;al</italic>., 2011</xref>; <xref rid="B34"
ref-type="bibr">Grimm <italic>et&#x000a0;al</italic>., 2011</xref>). Phosphatidylcholine levels are
reduced in cortical membranes (<xref rid="B79" ref-type="bibr">Nitsch
<italic>et&#x000a0;al</italic>., 1992</xref>) and erythrocytes (<xref rid="B86" ref-type="bibr"
>Selley, 2007</xref>) of AD patients, and studies of the global brain and plasma lipidomes in mouse
AD models revealed changes in several sterol, sphingolipid, and phospholipid species, each occurring
at specific stages of AD progression (<xref rid="B92" ref-type="bibr">Tajima
<italic>et&#x000a0;al.</italic>, 2013</xref>). Deletion mutants identified in our screen related to
phospholipid metabolism included enzymes involved in the de novo synthesis of phosphatidylcholine
from phosphatidylserine and phosphatidylethanolamine (PE; <italic>PSD1</italic>,
<italic>CHO2</italic> and <italic>OPI3</italic>; <xref rid="B55" ref-type="bibr">Kodaki and
Yamashita, 1987</xref>; <xref rid="B91" ref-type="bibr">Summers <italic>et&#x000a0;al</italic>.,
1988</xref>; <xref rid="B73" ref-type="bibr">McGraw and Henry, 1989</xref>) and both members of a
heterodimeric transcription complex positively regulating the transcription of a large family of
phospholipid biosynthetic genes (including <italic>OPI3</italic>; <xref rid="B65" ref-type="bibr"
>Loewy and Henry, 1984</xref>; <xref rid="B41" ref-type="bibr">Hirsch and Henry, 1986</xref>; <xref
rid="B6" ref-type="bibr">Bailis <italic>et&#x000a0;al</italic>., 1987</xref>; <xref rid="B48"
ref-type="bibr">Jesch <italic>et&#x000a0;al</italic>., 2005</xref>).</p>
<p>Defects in these PC biosynthetic pathways lead to accumulation of PC precursors, such as PE and
phosphatidylmonomethylethanolamine and altered membrane composition (<xref rid="B52" ref-type="bibr"
>Kennedy and Weiss, 1956</xref>). Supplementation with choline or dimethylethanolamine restores
normal synthesis of PC via the Kennedy salvage pathway (<xref rid="B52" ref-type="bibr">Kennedy and
Weiss, 1956</xref>; <xref rid="B73" ref-type="bibr">McGraw and Henry, 1989</xref>) and, in this
study, significantly reduced A&#x003b2;42-GFP fluorescence in &#x00394;<italic>opi3</italic> cells.
Of interest, mutations in <italic>PEMT</italic>, the human homologue of yeast <italic>OPI3</italic>,
are associated with increased risk of developing AD (<xref rid="B7" ref-type="bibr">Bi
<italic>et&#x000a0;al.</italic>, 2011</xref>). <italic>SCS2</italic> encodes a key ER regulator of
inositol and phospholipid metabolism (<xref rid="B33" ref-type="bibr">Greenberg
<italic>et&#x000a0;al</italic>., 1982</xref>; <xref rid="B49" ref-type="bibr">Kagiwada
<italic>et&#x000a0;al</italic>., 1998</xref>; <xref rid="B23" ref-type="bibr">Gavin
<italic>et&#x000a0;al</italic>., 2002</xref>; <xref rid="B64" ref-type="bibr">Loewen
<italic>et&#x000a0;al</italic>., 2003</xref>), with &#x00394;<italic>scs2</italic> mutants
accumulating 10% more PC than wild-type cells (<xref rid="B50" ref-type="bibr">Kagiwada and Zen,
2003</xref>). Thus, the intense A&#x003b2;42-GFP fluorescence in &#x00394;<italic>scs2</italic>
mutants indicates that PC depletion alone is unlikely to be the underlying cause of altered
A&#x003b2;42-GFP fluorescence in &#x00394;<italic>opi3</italic> and &#x00394;<italic>cho2</italic>
cells. We demonstrated that overexpression of CDP-diacylglycerol synthase (<italic>CDS1</italic>),
responsible for synthesis of the global phospholipid precursor CDP-diacylglycerol, also resulted in
increased A&#x003b2;42-GFP fluorescence. Together these results indicate overall perturbation of
normal phospholipid homeostasis and membrane composition rather than changes in a single lipid
species as being an important regulator of A&#x003b2; aggregation.</p>
<p>A&#x003b2;40/42 peptides may be absorbed onto phospholipid membranes (<xref rid="B94"
ref-type="bibr">Terzi <italic>et&#x000a0;al</italic>., 1997</xref>; <xref rid="B51" ref-type="bibr"
>Kanfer <italic>et&#x000a0;al</italic>., 1999</xref>; <xref rid="B17" ref-type="bibr">Ege and Lee,
2004</xref>; <xref rid="B18" ref-type="bibr">Ege <italic>et&#x000a0;al</italic>., 2005</xref>), and
there is strong evidence that lipid composition modulates the association, dissociation, and
aggregation of A&#x003b2; on membranes (<xref rid="B67" ref-type="bibr">Maltseva and Brezesinski,
2004</xref>; <xref rid="B68" ref-type="bibr">Maltseva <italic>et&#x000a0;al</italic>., 2005</xref>;
<xref rid="B12" ref-type="bibr">Chi <italic>et&#x000a0;al</italic>, 2008</xref>; <xref rid="B37"
ref-type="bibr">Hane <italic>et&#x000a0;al.</italic>, 2011</xref>; <xref rid="B60" ref-type="bibr"
>Lemkul and Bevan, 2011</xref>). The influence of membrane composition on A&#x003b2; dynamics
suggests a mechanism for the changes in A&#x003b2;42-GFP fluorescence observed in
<italic>&#x00394;ino2</italic>, <italic>&#x00394;ino4</italic>, <italic>&#x00394;psd1</italic>,
<italic>&#x00394;opi3</italic>, and <italic>&#x00394;cho2</italic> mutants and
<italic>CDS1</italic>-overexpressing cells. In these strains, disrupted lipid homeostasis alters
normal membrane composition, including incorporation of intermediates of phospholipid biosynthetic
pathways. A&#x003b2;42-GFP interaction with these membranes may be altered, favoring reduced
aggregation of A&#x003b2; and increased fluorescence. The distinctive perinuclear ER
membrane&#x02013;like localization of A&#x003b2;42-GFP fluorescence in these strains indicates that
such compositional changes are localized to specific organelles or subcellular regions. A detailed
subcellular lipidomic analysis of organelle-specific membranes may provide data to further test this
hypothesis, allowing in vitro measurement of A&#x003b2; aggregation on synthetic membranes, with
compositions matched to those of the mutants.</p>
<p>This study identifies specific genes and broader functional classes that influence the
aggregation of an A&#x003b2;42-GFP fusion protein in the cytosol of yeast, complementing recent
screens focusing on intracellular A&#x003b2; toxicity (<xref rid="B96" ref-type="bibr">Treusch
<italic>et&#x000a0;al</italic>., 2011</xref>; <xref rid="B16" ref-type="bibr">D'Angelo
<italic>et&#x000a0;al.</italic>, 2013</xref>. We found that deletion of <italic>PBS2</italic>,
encoding a mitogen-activated protein (MAP) kinase of the high osmolarity glycerol (HOG) pathway,
resulted in the appearance of a single intense, punctate fluorescent A&#x003b2;42-GFP structure in
cells, and <xref rid="B96" ref-type="bibr">Treusch <italic>et&#x000a0;al</italic>. (2011)</xref>
determined that overexpression of <italic>PBS2</italic> enhanced toxicity of A&#x003b2; expressed in
the yeast endoplasmic reticulum and that expression of the human <italic>PBS2</italic> homologue,
MAP2K4, in a <italic>Caenorhabditis elegans</italic> neuronal model resulted in enhanced cell death.
These complementary results together suggest that altered intracellular A&#x003b2; aggregation may
contribute to A&#x003b2;-induced cell toxicity in which signaling in the HOG pathway is compromised.
The high concordance of functional classes identified in our screen with those affected in animal AD
models and AD patients, particularly related to the TCA cycle, inositol metabolism, and phospholipid
homeostasis, hints at the involvement of novel modulators of intracellular A&#x003b2; aggregation in
the development of the disease in humans.</p>
</sec>
<sec sec-type="materials|methods">
<title>MATERIALS AND METHODS</title>
<sec>
<title>Strains and culture conditions</title>
<p><italic>S. cerevisiae</italic> homozygous diploid deletants for all nonessential genes were
obtained from the European <italic>Saccharomyces cerevisiae</italic> Archive for Functional Analysis
(<xref rid="B105" ref-type="bibr">Winzeler <italic>et&#x000a0;al</italic>., 1999</xref>). These
deletants were produced in the BY4743 diploid strain background
(<italic>MAT</italic><bold>a</bold><italic>/MAT&#x003b1; his3&#x00394;1/his3&#x00394;1
leu2&#x00394;0/leu2&#x00394;0 met15&#x00394;0/MET15 LYS2/lys2&#x00394;0
ura3&#x00394;0/ura3&#x00394;0</italic>), which was used as the wild-type reference strain. Standard
yeast growth media and techniques were used throughout this study. Yeast strains were grown in YEPD
medium (2% [wt/vol] glucose, 2% [wt/vol] peptone, 1% yeast extract) or synthetic defined complete
medium (SC; 2% [wt/vol] glucose, 0.17% yeast nitrogen base without amino acids [Becton Dickinson,
Franklin Lakes, NJ], 5% [wt/vol] ammonium sulfate [Sigma, St. Louis, MO]) supplemented with
appropriate amino acids and bases as indicated in Supplemental Table S1. Expression of genes under
the control of the <italic>GAL1</italic> promoter was induced by growth in induction medium
(SC-galactose; SC medium with 2% [wt/vol] galactose instead of glucose). Where required,
filter-sterilized phospholipid precursors were added to SC or induction media at 1 mM final
concentration. Respiratory-incompetent (rho<sup>0</sup>) cells, lacking mitochondrial DNA, were
generated by ethidium bromide treatment of the wild-type strain (<xref rid="B21" ref-type="bibr">Fox
<italic>et&#x000a0;al</italic>., 1991</xref>), identified by their inability to grow on YEPG medium
and confirmed by a lack of mitochondrial DNA, visualized using 4,6-diamidino-2-phenylindole
dihydrochloride (DAPI [Sigma]). At least five independent rho<sup>0</sup> cells generated were
examined for each experiment. Unless otherwise stated, all other reagents were purchased from
Sigma.</p>
</sec>
<sec>
<title>Plasmid construction</title>
<p>A derivative of the pUG35GFP fusion vector (<ext-link ext-link-type="uri"
xlink:href="http://mips.gsf.de/proj/yeast/info/tools/hege"
>http://mips.gsf.de/proj/yeast/info/tools/hegemann/gfp.html</ext-link>) containing the
<italic>GAL1</italic> promoter was created by excising the <italic>MET25</italic> promoter from
pUG35 by digestion with <italic>Sac</italic>I and <italic>Xba</italic>I. The <italic>GAL1</italic>
promoter was amplified from a pESC-URA template (Stratagene), using primers ESC-URA-F and ESC-URA-R
(Supplemental Table S2) containing <italic>Sac</italic>I and <italic>Xba</italic>I restriction
sites, respectively. The fragment containing <italic>GAL1</italic> was ligated into pUG35 to produce
pUG35GAL1. To generate A&#x003b2;-GFP fusion constructs for the deletion library screen,
A&#x003b2;42 coding sequence was amplified using pAS1N.A&#x003b2;GFP plasmid DNA (<xref rid="B9"
ref-type="bibr">Caine <italic>et&#x000a0;al</italic>., 2007</xref>) as a template. The
<italic>C</italic>-terminus of A&#x003b2;42 was fused to the N-terminus of GFP (including a
four&#x02013;amino acid linker) by amplifying the A&#x003b2;42 coding sequence, using primers
ABETA-F and ABETA-R containing <italic>Bam</italic>HI and <italic>Sal</italic>I sites, respectively.
After digestion with these enzymes, the A&#x003b2;42 fragment was ligated into pUG35GAL1 to produce
plasmid pA&#x003b2;42-GFP. Similarly, GFP fusions of the C-terminally truncated A&#x003b2;40-GFP and
a mutant form of A&#x003b2;42 (with amino acid substitutions I41E and A42P) were created by
amplification using ABETA-F with ABETA-40-R and ABETA-EP-R primers, respectively, to yield
pA&#x003b2;42-GFP and pA&#x003b2;EP-GFP. To generate A&#x003b2;-GFP fusion constructs for the
overexpression screen, the respective PCR fragments were used for the BP reaction of the Gateway
system (Invitrogen, San Diego, CA) with the destination vector pDonr221. The resulting plasmids,
pDonr221-A&#x003b2;42-GFP/pDonr221-A&#x003b2;40-GFP/pDonr221-A&#x003b2;EP-GFP/pDonr221-EGFP, were
used for the LR reaction using the destination vector pAG415GAL-ccdB and pAG416GAL-ccdB (<xref
rid="B1" ref-type="bibr">Alberti <italic>et&#x000a0;al</italic>., 2007</xref>). Plasmids were
maintained and amplified in <italic>E. coli</italic> DH5-&#x003b1; cells. For gene overexpression
experiments, high-copy galactose-inducible plasmids of the Yeast ORF Collection containing
<italic>S. cerevisiae</italic> open reading frames in the BG1805 plasmid background were used (<xref
rid="B25" ref-type="bibr">Gelperin <italic>et&#x000a0;al</italic>., 2005</xref>; Thermo
Scientific).</p>
</sec>
<sec>
<title>Protein extraction, SDS&#x02013;PAGE, and Western blot analysis</title>
<p>Yeast cultures (50 ml) were grown to OD<sub>600</sub> of 1.5 in induction medium (SC-galactose)
lacking uracil at 30&#x000b0;C. Cells were harvested, washed with water, and lysed by shaking with
glass beads in ice-cold lysis buffer (0.1 mM Tris-HCl, pH 8.0) supplemented with protease inhibitors
(Complete; Roche). Intact cells and large debris were removed by centrifugation at 2000 rpm for 5
min at 4&#x000b0;C. Supernatant from this step was subject to ultracentrifugation at 100,000
&#x000d7; <italic>g</italic> for 1 h at 4&#x000b0;C to yield a supernatant fraction containing
soluble proteins and an insoluble pellet. The pellet was solubilized by agitation in 2% SDS at
100&#x000b0;C. Total protein concentration for both supernatant and pellet fractions was determined
by BCA Protein Assay (Pierce Biotechnology, Rockford, IL), which was used to normalize protein
loading onto 4&#x02013;12% gradient SDS&#x02013;PAGE gels (20 &#x003bc;g/lane for supernatant
fractions, 5 &#x003bc;g/lane for pellet fractions). Proteins were electroblotted onto nitrocellulose
membranes for Western blotting and probed with mouse anti-A&#x003b2; (6E10; Covance, Sydney,
Australia) antibodies overnight at 1:1000 dilution. Immunodetection was performed using horseradish
peroxidase&#x02013;conjugated anti-mouse secondary antibodies (Jackson ImmunoResearch, West Grove,
PA), chemiluminescence reagents (Bio-Rad, Sydney, Australia), and ChemiDoc MP charge-coupled device
imaging system (Bio-Rad). Analysis and quantitation of Western blot images was performed using
ImageJ, version 1.38 (National Institutes of Health, Bethesda, MD).</p>
</sec>
<sec>
<title>High-throughput transformation of the <italic>S</italic>. <italic>cerevisiae</italic> genome
knockout collection</title>
<p>Microtiter plates containing strains from the <italic>S</italic>. <italic>cerevisiae</italic>
genome-wide deletion collection were replicated into 96-well plates containing 160 &#x003bc;l of
YEPD medium/well and incubated at 30&#x000b0;C with shaking for 1 d. Cells were pelleted and
resuspended in 20 &#x003bc;l of sterile MilliQ water before the addition of 160 &#x003bc;l of
transformation mix/well (40% [wt/vol] PEG-3350, 100 mM lithium acetate, 1 mM EDTA, 10 mM Tris-HCl,
pH 7.5, 20 ng/ml single-stranded herring sperm DNA, and 5 &#x003bc;g/well pA&#x003b2;42-GFP plasmid
DNA). Plates were incubated at 30&#x000b0;C overnight, followed by heat shock at 42&#x000b0;C for 30
min. Cells were pelleted, resuspended in 150 &#x003bc;l of SC medium (lacking uracil for selection
of the pA&#x003b2;42-GFP plasmid), and incubated at 30&#x000b0;C with shaking for 2 d. Further
selection was performed by replicating cells into fresh 96-well plates (containing 150
&#x003bc;l/well of uracil-free SC media) and growing for 1 d. Strains were stored for later analysis
by resuspension in 10% (vol/vol) glycerol and freezing at &#x02212;80&#x000b0;C.</p>
</sec>
<sec>
<title>Epifluorescence and confocal microscopy, and the visualization of organelles</title>
<p>Fluorescence microscopy was performed using a Leica DM5500B microscope under 100&#x000d7;
objective. Nuclear and mitochondrial DNA were visualized by staining cells with DAPI. Images were
obtained and processed using the Leica Application Suite. Image overlays were performed using
ImageJ, version 1.38 software. Confocal fluorescence microscopy was performed using an Olympus
FV-1000 confocal microscope under 100&#x000d7; objective. GFP and DAPI images were visualized using
488- and 405-nm lasers, respectively. Three-dimensional confocal data analysis and image processing
were performed using the Imaris 7.2 software package (Bitplane). The appearance of rod-like regions
along the <italic>z</italic>-axis of A&#x003b2;42-GFP in the confocal image may be an artifact of
limitation in imaging resolution along this <italic>z</italic>-axis.</p>
</sec>
<sec>
<title>Screening and analyzing knockout mutants for A&#x003b2;42-GFP fluorescence</title>
<p>Strains transformed with pA&#x003b2;42-GFP were replicated and grown for 48 h with shaking at
30&#x000b0;C in microtiter plates containing 150 &#x000b5;l/well of induction medium. Strains were
replicated in microtiter plates and grown for a further 24 h before A&#x003b2;42-GFP fluorescence
was evaluated using fluorescence microscopy. A minimum of 900 cells per strain were examined for
presence of A&#x003b2;42-GFP fluorescence. Mutant strains exhibiting altered fluorescence were
subcultured in induction media and reexamined.</p>
<p>Positive strains were analyzed for overrepresentation of functional groups with Gene Ontology
(GO) and MIPS databases using GO Biological Process, GO Molecular Function, and GO Cellular
Component in the analysis. <italic>S. cerevisiae</italic> genes were mapped to human homologues
using the HomoloGene database (<ext-link ext-link-type="uri"
xlink:href="http://www.ncbi.nlm.nih.gov/sites/entrez?db=homologene"
>www.ncbi.nlm.nih.gov/sites/entrez?db=homologene</ext-link>). All other analyses of <italic>S.
cerevisiae</italic> genes and associated annotations were performed using the
<italic>Saccharomyces</italic> Genome Database and associated tools (<ext-link ext-link-type="uri"
xlink:href="http://www.yeastgenome.org">www.yeastgenome.org</ext-link>).</p>
</sec>
<sec>
<title>Subcellular fractionation</title>
<p>Subcellular fractions of <italic>S</italic>. <italic>cerevisiae</italic> cells were prepared as
previously described by <xref rid="B83" ref-type="bibr">Rosenberger <italic>et&#x000a0;al</italic>.
(2009)</xref> and the cross-contamination of the ER and mitochondrial fractions verified by Western
blot analysis using antibodies against Wbp1p and Por1p, respectively. Cells expressing
A&#x003b2;42-GFP were grown to exponential phase (OD<sub>600</sub> of 1.5) in galactose medium,
harvested, washed in distilled water, and converted to spheroplasts (<xref rid="B13" ref-type="bibr"
>Daum <italic>et&#x000a0;al</italic>., 1982</xref>). Preparation of spheroplasts was performed using
2 mg Zymolyase 20T/g cell wet weight and incubating for 1.5 h at 30&#x000b0;C shaking (600 rpm).
Spheroplasts were homogenized on ice using a Dounce homogenizer with a tight-fitting pestle and
centrifuged to remove unbroken cells and nuclei. For preparation of crude mitochondrial fraction,
cell lysates were centrifuged at 30,000 &#x000d7; <italic>g</italic> (30 min, 4&#x000b0;C). To
enrich for mitochondria, the resulting pellet was thrice resuspended in breakage buffer,
rehomogenized, and centrifuged. For preparation of crude ER microsomal fraction, the remaining
supernatant was centrifuged at 45,000 &#x000d7; <italic>g</italic> (45 min; 4&#x000b0;C). To enrich
for ER, the resulting pellet was resuspended in breakage buffer, rehomogenized, and centrifuged. To
validate lack of cross-contamination of subcellular fractions, proteins from ER and mitochondrial
fractions were precipitated with 50% trichloroacetic acid for 1 h on ice, and Western blot analysis
was subsequently performed as described.</p>
</sec>
<sec>
<title>Statistical analysis</title>
<p>Statistical analysis was performed using the unpaired Student's <italic>t</italic> test, using
Prism 5 for Windows, version 5.02 (GraphPad Software). Data are presented as mean &#x000b1; SD.
Significant differences are indicated by a <italic>p</italic> value for data in the text and
figures.</p>
</sec>
</sec>
<sec sec-type="supplementary-material">
<title>Supplementary Material</title>
<supplementary-material id="PMC_1" content-type="local-data">
<caption>
<title>Supplemental Materials</title>
</caption>
<media mimetype="text" mime-subtype="html" xlink:href="supp_25_15_2235__index.html"/>
<media xlink:role="associated-file" mimetype="application" mime-subtype="pdf"
xlink:href="supp_E13-04-0216v1_CombinedSupMats.pdf"/>
</supplementary-material>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="other">
<p>This article was published online ahead of print in MBoC in Press (<ext-link ext-link-type="uri"
xlink:href="http://www.molbiolcell.org/cgi/doi/10.1091/mbc.E13-04-0216"
>http://www.molbiolcell.org/cgi/doi/10.1091/mbc.E13-04-0216</ext-link>) on May 28, 2014.</p>
</fn>
<fn fn-type="other" id="FN1">
<p>*These authors contributed equally to this work.</p>
</fn>
</fn-group>
<ack>
<p>We thank Ian Macreadie for providing plasmid pAS1N.A&#x003b2;GFP; Phil Hogg for assistance with
flow cytometry; Katharina Mack, Geoff Kornfeld, Joyce Chiu, and Shixiong Tan for technical advice;
and Guenter Daum and Vid Vojko Flis for helpful discussion and techniques for subcellular
fractionation. This research was supported by grants from the Australian Research Council (I.W.D.),
Cancer Institute New South Wales (I.W.D., G.G.P.), and a University of New South Wales International
Postgraduate Research Scholarship (S.N.).</p>
</ack>
<glossary>
<title>Abbreviations used:</title>
<def-list>
<def-item>
<term id="G1">A&#x003b2;</term>
<def>
<p>amyloid-&#x003b2;</p>
</def>
</def-item>
<def-item>
<term id="G2">AD</term>
<def>
<p>Alzheimer's disease</p>
</def>
</def-item>
<def-item>
<term id="G3">PC</term>
<def>
<p>phosphatidylcholine</p>
</def>
</def-item>
<def-item>
<term id="G4">PE</term>
<def>
<p>phosphatidylethanolamine</p>
</def>
</def-item>
<def-item>
<term id="G5">TCA</term>
<def>
<p>tricarboxylic acid</p>
</def>
</def-item>
</def-list>
</glossary>
<ref-list>
<title>REFERENCES</title>
<ref id="B1">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Alberti</surname>
<given-names>S</given-names>
</name><name>
<surname>Gitler</surname>
<given-names>AD</given-names>
</name><name>
<surname>Lindquist</surname>
<given-names>S</given-names>
</name></person-group>
<article-title>A suite of Gateway cloning vectors for high-throughput genetic analysis in
<italic>Saccharomyces cerevisiae</italic></article-title>
<source>Yeast</source>
<year>2007</year>
<volume>24</volume>
<fpage>913</fpage>
<lpage>919</lpage>
<pub-id pub-id-type="pmid">17583893</pub-id>
</element-citation>
</ref>
<ref id="B2">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Almeida</surname>
<given-names>CG</given-names>
</name><name>
<surname>Takahashi</surname>
<given-names>RH</given-names>
</name><name>
<surname>Gouras</surname>
<given-names>GK</given-names>
</name></person-group>
<article-title>Beta-amyloid accumulation impairs multivesicular body sorting by inhibiting the
ubiquitin-proteasome system</article-title>
<source>J Neurosci</source>
<year>2006</year>
<volume>26</volume>
<fpage>4277</fpage>
<lpage>4288</lpage>
<pub-id pub-id-type="pmid">16624948</pub-id>
</element-citation>
</ref>
<ref id="B3">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Ambroziak</surname>
<given-names>J</given-names>
</name><name>
<surname>Henry</surname>
<given-names>SA</given-names>
</name></person-group>
<article-title><italic>INO2</italic> and <italic>INO4</italic> gene products, positive regulators of
phospholipid biosynthesis in <italic>Saccharomyces cerevisiae</italic>, form a complex that binds to
the <italic>INO1</italic> promoter</article-title>
<source>J Biol Chem</source>
<year>1994</year>
<volume>269</volume>
<fpage>15344</fpage>
<lpage>15349</lpage>
<pub-id pub-id-type="pmid">8195172</pub-id>
</element-citation>
</ref>
<ref id="B4">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Atamna</surname>
<given-names>H</given-names>
</name><name>
<surname>Frey</surname>
<given-names>WH</given-names>
</name></person-group>
<article-title>Mechanisms of mitochondrial dysfunction and energy deficiency in Alzheimer's
disease</article-title>
<source>Mitochondrion</source>
<year>2007</year>
<volume>7</volume>
<fpage>297</fpage>
<lpage>310</lpage>
<pub-id pub-id-type="pmid">17625988</pub-id>
</element-citation>
</ref>
<ref id="B5">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Aytan</surname>
<given-names>N</given-names>
</name><name>
<surname>Choi</surname>
<given-names>JK</given-names>
</name><name>
<surname>Carreras</surname>
<given-names>I</given-names>
</name><name>
<surname>Kowall</surname>
<given-names>NW</given-names>
</name><name>
<surname>Jenkins</surname>
<given-names>BG</given-names>
</name><name>
<surname>Dedeoglu</surname>
<given-names>A</given-names>
</name></person-group>
<article-title>Combination therapy in a transgenic model of Alzheimer's disease</article-title>
<source>Exp Neurol</source>
<year>2013</year>
<volume>250C</volume>
<fpage>228</fpage>
<lpage>238</lpage>
<pub-id pub-id-type="pmid">24120437</pub-id>
</element-citation>
</ref>
<ref id="B6">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Bailis</surname>
<given-names>AM</given-names>
</name><name>
<surname>Poole</surname>
<given-names>MA</given-names>
</name><name>
<surname>Carman</surname>
<given-names>GM</given-names>
</name><name>
<surname>Henry</surname>
<given-names>SA</given-names>
</name></person-group>
<article-title>The membrane-associated enzyme phosphatidylserine synthase is regulated at the level
of mRNA abundance</article-title>
<source>Mol Cell Biol</source>
<year>1987</year>
<volume>7</volume>
<fpage>167</fpage>
<lpage>176</lpage>
<pub-id pub-id-type="pmid">3031455</pub-id>
</element-citation>
</ref>
<ref id="B7">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Bi</surname>
<given-names>X-H</given-names>
</name><name>
<surname>Zhao</surname>
<given-names>H-L</given-names>
</name><name>
<surname>Zhang</surname>
<given-names>Z-X</given-names>
</name><name>
<surname>Zhang</surname>
<given-names>J-W</given-names>
</name></person-group>
<article-title>PEMT G523A (V175M) is associated with sporadic Alzheimer's disease in a Chinese
population</article-title>
<source>J Mol Neurosci</source>
<year>2011</year>
<volume>46</volume>
<fpage>505</fpage>
<lpage>508</lpage>
<pub-id pub-id-type="pmid">21881829</pub-id>
</element-citation>
</ref>
<ref id="B8">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Bubber</surname>
<given-names>P</given-names>
</name><name>
<surname>Haroutunian</surname>
<given-names>V</given-names>
</name><name>
<surname>Fisch</surname>
<given-names>G</given-names>
</name><name>
<surname>Blass</surname>
<given-names>JP</given-names>
</name><name>
<surname>Gibson</surname>
<given-names>GE</given-names>
</name></person-group>
<article-title>Mitochondrial abnormalities in Alzheimer brain: mechanistic
implications</article-title>
<source>Ann Neurol</source>
<year>2005</year>
<volume>57</volume>
<fpage>695</fpage>
<lpage>703</lpage>
<pub-id pub-id-type="pmid">15852400</pub-id>
</element-citation>
</ref>
<ref id="B9">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Caine</surname>
<given-names>J</given-names>
</name><name>
<surname>Sankovich</surname>
<given-names>S</given-names>
</name><name>
<surname>Antony</surname>
<given-names>H</given-names>
</name><name>
<surname>Waddington</surname>
<given-names>L</given-names>
</name><name>
<surname>Macreadie</surname>
<given-names>P</given-names>
</name><name>
<surname>Varghese</surname>
<given-names>J</given-names>
</name><name>
<surname>Macreadie</surname>
<given-names>I</given-names>
</name></person-group>
<article-title>Alzheimer's Abeta fused to green fluorescent protein induces growth stress and a heat
shock response</article-title>
<source>FEMS Yeast Res</source>
<year>2007</year>
<volume>7</volume>
<fpage>1230</fpage>
<lpage>1236</lpage>
<pub-id pub-id-type="pmid">17662055</pub-id>
</element-citation>
</ref>
<ref id="B10">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Caspersen</surname>
<given-names>C</given-names>
</name><name>
<surname>Wang</surname>
<given-names>N</given-names>
</name><name>
<surname>Yao</surname>
<given-names>J</given-names>
</name><name>
<surname>Sosunov</surname>
<given-names>A</given-names>
</name><name>
<surname>Chen</surname>
<given-names>X</given-names>
</name><name>
<surname>Lustbader</surname>
<given-names>JW</given-names>
</name><name>
<surname>Xu</surname>
<given-names>HW</given-names>
</name><name>
<surname>Stern</surname>
<given-names>D</given-names>
</name><name>
<surname>McKhann</surname>
<given-names>G</given-names>
</name><name>
<surname>Yan</surname>
<given-names>SD</given-names>
</name></person-group>
<article-title>Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in
Alzheimer's disease</article-title>
<source>FASEB J</source>
<year>2005</year>
<volume>19</volume>
<fpage>2040</fpage>
<lpage>2041</lpage>
<pub-id pub-id-type="pmid">16210396</pub-id>
</element-citation>
</ref>
<ref id="B11">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Chaturvedi</surname>
<given-names>RK</given-names>
</name><name>
<surname>Beal</surname>
<given-names>MF</given-names>
</name></person-group>
<article-title>Mitochondria targeted therapeutic approaches in Parkinson's and Huntington's
diseases</article-title>
<source>Mol Cell Neurosci</source>
<year>2013</year>
<volume>55</volume>
<fpage>101</fpage>
<lpage>114</lpage>
<pub-id pub-id-type="pmid">23220289</pub-id>
</element-citation>
</ref>
<ref id="B12">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Chi</surname>
<given-names>EY</given-names>
</name><name>
<surname>Ege</surname>
<given-names>C</given-names>
</name><name>
<surname>Winans</surname>
<given-names>A</given-names>
</name><name>
<surname>Majewski</surname>
<given-names>J</given-names>
</name><name>
<surname>Wu</surname>
<given-names>G</given-names>
</name><name>
<surname>Kjaer</surname>
<given-names>K</given-names>
</name><name>
<surname>Lee</surname>
<given-names>KYC</given-names>
</name></person-group>
<article-title>Lipid membrane templates the ordering and induces the fibrillogenesis of Alzheimer's
disease amyloid-&#x003b2; peptide</article-title>
<source>Proteins</source>
<year>2008</year>
<volume>72</volume>
<fpage>1</fpage>
<lpage>24</lpage>
<pub-id pub-id-type="pmid">18186465</pub-id>
</element-citation>
</ref>
<ref id="B13">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Daum</surname>
<given-names>G</given-names>
</name><name>
<surname>Bohni</surname>
<given-names>PC</given-names>
</name><name>
<surname>Schatz</surname>
<given-names>G</given-names>
</name></person-group>
<article-title>Import of proteins into mitochondria. Cytochrome b2 and cytochrome c peroxidase are
located in the intermembrane space of yeast mitochondria</article-title>
<source>J Biol Chem</source>
<year>1982</year>
<volume>257</volume>
<fpage>13028</fpage>
<lpage>13033</lpage>
<pub-id pub-id-type="pmid">6290489</pub-id>
</element-citation>
</ref>
<ref id="B16">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>D'Angelo</surname>
<given-names>F</given-names>
</name><name>
<surname>Vignaud</surname>
<given-names>H</given-names>
</name><name>
<surname>Di Martino</surname>
<given-names>J</given-names>
</name><name>
<surname>Salin</surname>
<given-names>B</given-names>
</name><name>
<surname>Devin</surname>
<given-names>A</given-names>
</name><name>
<surname>Cullin</surname>
<given-names>C</given-names>
</name><name>
<surname>Marchal</surname>
<given-names>C</given-names>
</name></person-group>
<article-title>A yeast model for amyloid-beta aggregation exemplifies the role of membrane
trafficking and PICALM in cytotoxicity</article-title>
<source>Dis Model Mech</source>
<year>2013</year>
<volume>6</volume>
<fpage>206</fpage>
<lpage>216</lpage>
<pub-id pub-id-type="pmid">22888099</pub-id>
</element-citation>
</ref>
<ref id="B14">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>de Leon</surname>
<given-names>MJ</given-names>
</name><etal/></person-group>
<article-title>Positron emission tomographic studies of aging and Alzheimer disease</article-title>
<source>Am J Neuroradiol</source>
<year>1983</year>
<volume>4</volume>
<fpage>568</fpage>
<lpage>571</lpage>
<pub-id pub-id-type="pmid">6410799</pub-id>
</element-citation>
</ref>
<ref id="B15">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Dimmer</surname>
<given-names>KS</given-names>
</name><name>
<surname>Fritz</surname>
<given-names>S</given-names>
</name><name>
<surname>Fuchs</surname>
<given-names>F</given-names>
</name><name>
<surname>Messerschmitt</surname>
<given-names>M</given-names>
</name><name>
<surname>Weinbach</surname>
<given-names>N</given-names>
</name><name>
<surname>Neupert</surname>
<given-names>W</given-names>
</name><name>
<surname>Westermann</surname>
<given-names>B</given-names>
</name></person-group>
<article-title>Genetic basis of mitochondrial function and morphology in <italic>Saccharomyces
cerevisiae</italic></article-title>
<source>Mol Biol Cell</source>
<year>2002</year>
<volume>13</volume>
<fpage>847</fpage>
<lpage>853</lpage>
<pub-id pub-id-type="pmid">11907266</pub-id>
</element-citation>
</ref>
<ref id="B17">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Ege</surname>
<given-names>C</given-names>
</name><name>
<surname>Lee</surname>
<given-names>KY</given-names>
</name></person-group>
<article-title>Insertion of Alzheimer's A beta 40 peptide into lipid monolayers</article-title>
<source>Biophys J</source>
<year>2004</year>
<volume>87</volume>
<fpage>1732</fpage>
<lpage>1740</lpage>
<pub-id pub-id-type="pmid">15345552</pub-id>
</element-citation>
</ref>
<ref id="B18">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Ege</surname>
<given-names>C</given-names>
</name><name>
<surname>Majewski</surname>
<given-names>J</given-names>
</name><name>
<surname>Wu</surname>
<given-names>G</given-names>
</name><name>
<surname>Kjaer</surname>
<given-names>K</given-names>
</name><name>
<surname>Lee</surname>
<given-names>KY</given-names>
</name></person-group>
<article-title>Templating effect of lipid membranes on Alzheimer's amyloid beta
peptide</article-title>
<source>Chemphyschem</source>
<year>2005</year>
<volume>6</volume>
<fpage>226</fpage>
<lpage>229</lpage>
<pub-id pub-id-type="pmid">15751341</pub-id>
</element-citation>
</ref>
<ref id="B19">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Epstein</surname>
<given-names>CB</given-names>
</name><name>
<surname>Waddle</surname>
<given-names>JA</given-names>
</name><name>
<surname>Hale</surname>
<given-names>WT</given-names>
</name><name>
<surname>Dave</surname>
<given-names>V</given-names>
</name><name>
<surname>Thornton</surname>
<given-names>J</given-names>
</name><name>
<surname>Macatee</surname>
<given-names>TL</given-names>
</name><name>
<surname>Garner</surname>
<given-names>HR</given-names>
</name><name>
<surname>Butow</surname>
<given-names>RA</given-names>
</name></person-group>
<article-title>Genome-wide responses to mitochondrial dysfunction</article-title>
<source>Mol Biol Cell</source>
<year>2001</year>
<volume>12</volume>
<fpage>297</fpage>
<lpage>308</lpage>
<pub-id pub-id-type="pmid">11179416</pub-id>
</element-citation>
</ref>
<ref id="B20">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Flower</surname>
<given-names>TR</given-names>
</name><name>
<surname>Chesnokova</surname>
<given-names>LS</given-names>
</name><name>
<surname>Froelich</surname>
<given-names>CA</given-names>
</name><name>
<surname>Dixon</surname>
<given-names>C</given-names>
</name><name>
<surname>Witt</surname>
<given-names>SN</given-names>
</name></person-group>
<article-title>Heat shock prevents alpha-synuclein-induced apoptosis in a yeast model of Parkinson's
disease</article-title>
<source>J Mol Biol</source>
<year>2005</year>
<volume>351</volume>
<fpage>1081</fpage>
<lpage>1100</lpage>
<pub-id pub-id-type="pmid">16051265</pub-id>
</element-citation>
</ref>
<ref id="B21">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Fox</surname>
<given-names>TD</given-names>
</name><name>
<surname>Folley</surname>
<given-names>LS</given-names>
</name><name>
<surname>Mulero</surname>
<given-names>JJ</given-names>
</name><name>
<surname>McMullin</surname>
<given-names>TW</given-names>
</name><name>
<surname>Thorsness</surname>
<given-names>PE</given-names>
</name><name>
<surname>Hedin</surname>
<given-names>LO</given-names>
</name><name>
<surname>Costanzo</surname>
<given-names>MC</given-names>
</name></person-group>
<article-title>Analysis and manipulation of yeast mitochondrial genes</article-title>
<source>Methods Enzymol</source>
<year>1991</year>
<volume>194</volume>
<fpage>149</fpage>
<lpage>165</lpage>
<pub-id pub-id-type="pmid">1706458</pub-id>
</element-citation>
</ref>
<ref id="B22">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Frisardi</surname>
<given-names>V</given-names>
</name><name>
<surname>Panza</surname>
<given-names>F</given-names>
</name><name>
<surname>Seripa</surname>
<given-names>D</given-names>
</name><name>
<surname>Farooqui</surname>
<given-names>T</given-names>
</name><name>
<surname>Farooqui</surname>
<given-names>AA</given-names>
</name></person-group>
<article-title>Glycerophospholipids and glycerophospholipid-derived lipid mediators: a complex
meshwork in Alzheimer's disease pathology</article-title>
<source>Prog Lipid Res</source>
<year>2011</year>
<volume>50</volume>
<fpage>313</fpage>
<lpage>330</lpage>
<pub-id pub-id-type="pmid">21703303</pub-id>
</element-citation>
</ref>
<ref id="B23">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Gavin</surname>
<given-names>AC</given-names>
</name><etal/></person-group>
<article-title>Functional organization of the yeast proteome by systematic analysis of protein
complexes</article-title>
<source>Nature</source>
<year>2002</year>
<volume>415</volume>
<fpage>141</fpage>
<lpage>147</lpage>
<pub-id pub-id-type="pmid">11805826</pub-id>
</element-citation>
</ref>
<ref id="B24">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Gellermann</surname>
<given-names>GP</given-names>
</name><name>
<surname>Ullrich</surname>
<given-names>K</given-names>
</name><name>
<surname>Unger</surname>
<given-names>C</given-names>
</name><name>
<surname>Fandrich</surname>
<given-names>M</given-names>
</name><name>
<surname>Sauter</surname>
<given-names>S</given-names>
</name><name>
<surname>Diekmann</surname>
<given-names>S</given-names>
</name></person-group>
<article-title>Identification of molecular compounds critical to Alzheimer's-like plaque
formation</article-title>
<source>J Neurosci Res</source>
<year>2007</year>
<volume>85</volume>
<fpage>2037</fpage>
<lpage>2044</lpage>
<pub-id pub-id-type="pmid">17492785</pub-id>
</element-citation>
</ref>
<ref id="B25">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Gelperin</surname>
<given-names>DM</given-names>
</name><etal/></person-group>
<article-title>Biochemical and genetic analysis of the yeast proteome with a movable ORF
collection</article-title>
<source>Genes Dev</source>
<year>2005</year>
<volume>19</volume>
<fpage>2816</fpage>
<lpage>2826</lpage>
<pub-id pub-id-type="pmid">16322557</pub-id>
</element-citation>
</ref>
<ref id="B26">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Giaever</surname>
<given-names>G</given-names>
</name><etal/></person-group>
<article-title>Functional profiling of the <italic>Saccharomyces cerevisiae</italic>
genome</article-title>
<source>Nature</source>
<year>2002</year>
<volume>418</volume>
<fpage>387</fpage>
<lpage>391</lpage>
<pub-id pub-id-type="pmid">12140549</pub-id>
</element-citation>
</ref>
<ref id="B27">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Gibson</surname>
<given-names>GE</given-names>
</name><name>
<surname>Blass</surname>
<given-names>JP</given-names>
</name><name>
<surname>Beal</surname>
<given-names>MF</given-names>
</name><name>
<surname>Bunik</surname>
<given-names>V</given-names>
</name></person-group>
<article-title>The alpha-ketoglutarate-dehydrogenase complex: a mediator between mitochondria and
oxidative stress in neurodegeneration</article-title>
<source>Mol Neurobiol</source>
<year>2005</year>
<volume>31</volume>
<fpage>43</fpage>
<lpage>63</lpage>
<pub-id pub-id-type="pmid">15953811</pub-id>
</element-citation>
</ref>
<ref id="B28">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Gibson</surname>
<given-names>GE</given-names>
</name><name>
<surname>Park</surname>
<given-names>LC</given-names>
</name><name>
<surname>Sheu</surname>
<given-names>KF</given-names>
</name><name>
<surname>Blass</surname>
<given-names>JP</given-names>
</name><name>
<surname>Calingasan</surname>
<given-names>NY</given-names>
</name></person-group>
<article-title>The alpha-ketoglutarate dehydrogenase complex in neurodegeneration</article-title>
<source>Neurochem Int</source>
<year>2000</year>
<volume>36</volume>
<fpage>97</fpage>
<lpage>112</lpage>
<pub-id pub-id-type="pmid">10676873</pub-id>
</element-citation>
</ref>
<ref id="B29">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Giorgini</surname>
<given-names>F</given-names>
</name><name>
<surname>Guidetti</surname>
<given-names>P</given-names>
</name><name>
<surname>Nguyen</surname>
<given-names>Q</given-names>
</name><name>
<surname>Bennett</surname>
<given-names>SC</given-names>
</name><name>
<surname>Muchowski</surname>
<given-names>PJ</given-names>
</name></person-group>
<article-title>A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic
target for Huntington disease</article-title>
<source>Nat Genet</source>
<year>2005</year>
<volume>37</volume>
<fpage>526</fpage>
<lpage>531</lpage>
<pub-id pub-id-type="pmid">15806102</pub-id>
</element-citation>
</ref>
<ref id="B30">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Glenner</surname>
<given-names>GG</given-names>
</name><name>
<surname>Wong</surname>
<given-names>CW</given-names>
</name></person-group>
<article-title>Alzheimer's disease: initial report of the purification and characterization of a
novel cerebrovascular amyloid protein</article-title>
<source>Biochem Biophys Res Commun</source>
<year>1984</year>
<volume>120</volume>
<fpage>885</fpage>
<lpage>890</lpage>
<pub-id pub-id-type="pmid">6375662</pub-id>
</element-citation>
</ref>
<ref id="B31">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Gouras</surname>
<given-names>GK</given-names>
</name><etal/></person-group>
<article-title>Intraneuronal Abeta42 accumulation in human brain</article-title>
<source>Am J Pathol</source>
<year>2000</year>
<volume>156</volume>
<fpage>15</fpage>
<lpage>20</lpage>
<pub-id pub-id-type="pmid">10623648</pub-id>
</element-citation>
</ref>
<ref id="B32">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Gouras</surname>
<given-names>GK</given-names>
</name><name>
<surname>Almeida</surname>
<given-names>CG</given-names>
</name><name>
<surname>Takahashi</surname>
<given-names>RH</given-names>
</name></person-group>
<article-title>Intraneuronal Abeta accumulation and origin of plaques in Alzheimer's
disease</article-title>
<source>Neurobiol Aging</source>
<year>2005</year>
<volume>26</volume>
<fpage>1235</fpage>
<lpage>1244</lpage>
<pub-id pub-id-type="pmid">16023263</pub-id>
</element-citation>
</ref>
<ref id="B33">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Greenberg</surname>
<given-names>ML</given-names>
</name><name>
<surname>Reiner</surname>
<given-names>B</given-names>
</name><name>
<surname>Henry</surname>
<given-names>SA</given-names>
</name></person-group>
<article-title>Regulatory mutations of inositol biosynthesis in yeast: isolation of
inositol-excreting mutants</article-title>
<source>Genetics</source>
<year>1982</year>
<volume>100</volume>
<fpage>19</fpage>
<lpage>33</lpage>
<pub-id pub-id-type="pmid">7047296</pub-id>
</element-citation>
</ref>
<ref id="B34">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Grimm</surname>
<given-names>MO</given-names>
</name><name>
<surname>Grosgen</surname>
<given-names>S</given-names>
</name><name>
<surname>Riemenschneider</surname>
<given-names>M</given-names>
</name><name>
<surname>Tanila</surname>
<given-names>H</given-names>
</name><name>
<surname>Grimm</surname>
<given-names>HS</given-names>
</name><name>
<surname>Hartmann</surname>
<given-names>T</given-names>
</name></person-group>
<article-title>From brain to food: analysis of phosphatidylcholins, lyso-phosphatidylcholins and
phosphatidylcholin-plasmalogens derivates in Alzheimer's disease human post mortem brains and mice
model via mass spectrometry</article-title>
<source>J Chromatogr</source>
<year>2011</year>
<volume>1218</volume>
<fpage>7713</fpage>
<lpage>7722</lpage>
</element-citation>
</ref>
<ref id="B35">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Haass</surname>
<given-names>C</given-names>
</name><name>
<surname>Selkoe</surname>
<given-names>DJ</given-names>
</name></person-group>
<article-title>Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid
beta-peptide</article-title>
<source>Nat Rev Mol Cell Biol</source>
<year>2007</year>
<volume>8</volume>
<fpage>101</fpage>
<lpage>112</lpage>
<pub-id pub-id-type="pmid">17245412</pub-id>
</element-citation>
</ref>
<ref id="B36">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Hamada</surname>
<given-names>D</given-names>
</name><name>
<surname>Tsumoto</surname>
<given-names>K</given-names>
</name><name>
<surname>Sawara</surname>
<given-names>M</given-names>
</name><name>
<surname>Tanaka</surname>
<given-names>N</given-names>
</name><name>
<surname>Nakahira</surname>
<given-names>K</given-names>
</name><name>
<surname>Shiraki</surname>
<given-names>K</given-names>
</name><name>
<surname>Yanagihara</surname>
<given-names>I</given-names>
</name></person-group>
<article-title>Effect of an amyloidogenic sequence attached to yellow fluorescent
protein</article-title>
<source>Proteins</source>
<year>2008</year>
<volume>72</volume>
<fpage>811</fpage>
<lpage>821</lpage>
<pub-id pub-id-type="pmid">18260107</pub-id>
</element-citation>
</ref>
<ref id="B37">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Hane</surname>
<given-names>F</given-names>
</name><name>
<surname>Drolle</surname>
<given-names>E</given-names>
</name><name>
<surname>Gaikwad</surname>
<given-names>R</given-names>
</name><name>
<surname>Faught</surname>
<given-names>E</given-names>
</name><name>
<surname>Leonenko</surname>
<given-names>Z</given-names>
</name></person-group>
<article-title>Amyloid-&#x003b2; aggregation on model lipid membranes: an atomic force microscopy
study</article-title>
<source>J Alzheimers Dis</source>
<year>2011</year>
<volume>26</volume>
<fpage>485</fpage>
<lpage>494</lpage>
<pub-id pub-id-type="pmid">21694459</pub-id>
</element-citation>
</ref>
<ref id="B38">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Hardy</surname>
<given-names>JA</given-names>
</name><name>
<surname>Higgins</surname>
<given-names>GA</given-names>
</name></person-group>
<article-title>Alzheimer's disease: the amyloid cascade hypothesis</article-title>
<source>Science</source>
<year>1992</year>
<volume>256</volume>
<fpage>184</fpage>
<lpage>185</lpage>
<pub-id pub-id-type="pmid">1566067</pub-id>
</element-citation>
</ref>
<ref id="B39">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Haris</surname>
<given-names>M</given-names>
</name><name>
<surname>Cai</surname>
<given-names>K</given-names>
</name><name>
<surname>Singh</surname>
<given-names>A</given-names>
</name><name>
<surname>Hariharan</surname>
<given-names>H</given-names>
</name><name>
<surname>Reddy</surname>
<given-names>R</given-names>
</name></person-group>
<article-title>In vivo mapping of brain myo-inositol</article-title>
<source>Neuroimage</source>
<year>2011</year>
<volume>54</volume>
<fpage>2079</fpage>
<lpage>2085</lpage>
<pub-id pub-id-type="pmid">20951217</pub-id>
</element-citation>
</ref>
<ref id="B40">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Hillenmeyer</surname>
<given-names>ME</given-names>
</name><etal/></person-group>
<article-title>The chemical genomic portrait of yeast: uncovering a phenotype for all
genes</article-title>
<source>Science</source>
<year>2008</year>
<volume>320</volume>
<fpage>362</fpage>
<lpage>365</lpage>
<pub-id pub-id-type="pmid">18420932</pub-id>
</element-citation>
</ref>
<ref id="B41">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Hirsch</surname>
<given-names>JP</given-names>
</name><name>
<surname>Henry</surname>
<given-names>SA</given-names>
</name></person-group>
<article-title>Expression of the <italic>Saccharomyces cerevisiae</italic> inositol-1-phosphate
synthase (<italic>INO1</italic>) gene is regulated by factors that affect phospholipid
synthesis</article-title>
<source>Mol Cell Biol</source>
<year>1986</year>
<volume>6</volume>
<fpage>3320</fpage>
<lpage>3328</lpage>
<pub-id pub-id-type="pmid">3025587</pub-id>
</element-citation>
</ref>
<ref id="B42">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Homann</surname>
<given-names>MJ</given-names>
</name><name>
<surname>Henry</surname>
<given-names>SA</given-names>
</name><name>
<surname>Carman</surname>
<given-names>GM</given-names>
</name></person-group>
<article-title>Regulation of CDP-diacyl&#x000ad;glycerol synthase activity in <italic>Saccharomyces
cerevisiae</italic></article-title>
<source>J Bacteriol</source>
<year>1985</year>
<volume>163</volume>
<fpage>1265</fpage>
<lpage>1266</lpage>
<pub-id pub-id-type="pmid">2993242</pub-id>
</element-citation>
</ref>
<ref id="B43">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Howlett</surname>
<given-names>DR</given-names>
</name><name>
<surname>Jennings</surname>
<given-names>KH</given-names>
</name><name>
<surname>Lee</surname>
<given-names>DC</given-names>
</name><name>
<surname>Clark</surname>
<given-names>MS</given-names>
</name><name>
<surname>Brown</surname>
<given-names>F</given-names>
</name><name>
<surname>Wetzel</surname>
<given-names>R</given-names>
</name><name>
<surname>Wood</surname>
<given-names>SJ</given-names>
</name><name>
<surname>Camilleri</surname>
<given-names>P</given-names>
</name><name>
<surname>Roberts</surname>
<given-names>GW</given-names>
</name></person-group>
<article-title>Aggregation state and neurotoxic properties of Alzheimer beta-amyloid
peptide</article-title>
<source>Neurodegeneration</source>
<year>1995</year>
<volume>4</volume>
<fpage>23</fpage>
<lpage>32</lpage>
<pub-id pub-id-type="pmid">7600183</pub-id>
</element-citation>
</ref>
<ref id="B44">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Hung</surname>
<given-names>LW</given-names>
</name><name>
<surname>Ciccotosto</surname>
<given-names>GD</given-names>
</name><name>
<surname>Giannakis</surname>
<given-names>E</given-names>
</name><name>
<surname>Tew</surname>
<given-names>DJ</given-names>
</name><name>
<surname>Perez</surname>
<given-names>K</given-names>
</name><name>
<surname>Masters</surname>
<given-names>CL</given-names>
</name><name>
<surname>Cappai</surname>
<given-names>R</given-names>
</name><name>
<surname>Wade</surname>
<given-names>JD</given-names>
</name><name>
<surname>Barnham</surname>
<given-names>KJ</given-names>
</name></person-group>
<article-title>Amyloid-beta peptide (Abeta) neurotoxicity is modulated by the rate of peptide
aggregation: Abeta dimers and trimers correlate with neurotoxicity</article-title>
<source>J Neurosci</source>
<year>2008</year>
<volume>28</volume>
<fpage>11950</fpage>
<lpage>11958</lpage>
<pub-id pub-id-type="pmid">19005060</pub-id>
</element-citation>
</ref>
<ref id="B45">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Jarrett</surname>
<given-names>JT</given-names>
</name><name>
<surname>Berger</surname>
<given-names>EP</given-names>
</name><name>
<surname>Lansbury</surname>
<given-names>PT</given-names>
<suffix>Jr</suffix>
</name></person-group>
<article-title>The carboxy terminus of the beta amyloid protein is critical for the seeding of
amyloid formation: implications for the pathogenesis of Alzheimer's disease</article-title>
<source>Biochemistry</source>
<year>1993</year>
<volume>32</volume>
<fpage>4693</fpage>
<lpage>4697</lpage>
<pub-id pub-id-type="pmid">8490014</pub-id>
</element-citation>
</ref>
<ref id="B46">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Jarrett</surname>
<given-names>JT</given-names>
</name><name>
<surname>Lansbury</surname>
<given-names>PT</given-names>
<suffix>Jr</suffix>
</name></person-group>
<article-title>Seeding &#x0201c;one-dimensional crystallization&#x0201d; of amyloid: a pathogenic
mechanism in Alzheimer's disease and scrapie?</article-title>
<source>Cell</source>
<year>1993</year>
<volume>73</volume>
<fpage>1055</fpage>
<lpage>1058</lpage>
<pub-id pub-id-type="pmid">8513491</pub-id>
</element-citation>
</ref>
<ref id="B47">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Jelicic</surname>
<given-names>B</given-names>
</name><name>
<surname>Traven</surname>
<given-names>A</given-names>
</name><name>
<surname>Filic</surname>
<given-names>V</given-names>
</name><name>
<surname>Sopta</surname>
<given-names>M</given-names>
</name></person-group>
<article-title>Mitochondrial dysfunction enhances Gal4-dependent transcription</article-title>
<source>FEMS Microbiol Lett</source>
<year>2005</year>
<volume>253</volume>
<fpage>207</fpage>
<lpage>213</lpage>
<pub-id pub-id-type="pmid">16239078</pub-id>
</element-citation>
</ref>
<ref id="B48">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Jesch</surname>
<given-names>SA</given-names>
</name><name>
<surname>Zhao</surname>
<given-names>X</given-names>
</name><name>
<surname>Wells</surname>
<given-names>MT</given-names>
</name><name>
<surname>Henry</surname>
<given-names>SA</given-names>
</name></person-group>
<article-title>Genome-wide analysis reveals inositol, not choline, as the major effector of
Ino2p-Ino4p and unfolded protein response target gene expression in yeast</article-title>
<source>J Biol Chem</source>
<year>2005</year>
<volume>280</volume>
<fpage>9106</fpage>
<lpage>9118</lpage>
<pub-id pub-id-type="pmid">15611057</pub-id>
</element-citation>
</ref>
<ref id="B49">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Kagiwada</surname>
<given-names>S</given-names>
</name><name>
<surname>Hosaka</surname>
<given-names>K</given-names>
</name><name>
<surname>Murata</surname>
<given-names>M</given-names>
</name><name>
<surname>Nikawa</surname>
<given-names>J</given-names>
</name><name>
<surname>Takatsuki</surname>
<given-names>A</given-names>
</name></person-group>
<article-title>The <italic>Saccharomyces cerevisiae SCS2</italic> gene product, a homolog of a
synaptobrevin-associated protein, is an integral membrane protein of the endoplasmic reticulum and
is required for inositol metabolism</article-title>
<source>J Bacteriol</source>
<year>1998</year>
<volume>180</volume>
<fpage>1700</fpage>
<lpage>1708</lpage>
<pub-id pub-id-type="pmid">9537365</pub-id>
</element-citation>
</ref>
<ref id="B50">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Kagiwada</surname>
<given-names>S</given-names>
</name><name>
<surname>Zen</surname>
<given-names>R</given-names>
</name></person-group>
<article-title>Role of the yeast VAP homolog, Scs2p, in <italic>INO1</italic> expression and
phospholipid metabolism</article-title>
<source>J Biochem</source>
<year>2003</year>
<volume>133</volume>
<fpage>515</fpage>
<lpage>522</lpage>
<pub-id pub-id-type="pmid">12761300</pub-id>
</element-citation>
</ref>
<ref id="B51">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Kanfer</surname>
<given-names>JN</given-names>
</name><name>
<surname>Sorrentino</surname>
<given-names>G</given-names>
</name><name>
<surname>Sitar</surname>
<given-names>DS</given-names>
</name></person-group>
<article-title>Amyloid beta peptide membrane perturbation is the basis for its biological
effects</article-title>
<source>Neurochem Res</source>
<year>1999</year>
<volume>24</volume>
<fpage>1621</fpage>
<lpage>1630</lpage>
<pub-id pub-id-type="pmid">10591414</pub-id>
</element-citation>
</ref>
<ref id="B52">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Kennedy</surname>
<given-names>EP</given-names>
</name><name>
<surname>Weiss</surname>
<given-names>SB</given-names>
</name></person-group>
<article-title>The function of cytidine coenzymes in the biosynthesis of
phospholipids</article-title>
<source>J Biol Chem</source>
<year>1956</year>
<volume>222</volume>
<fpage>193</fpage>
<lpage>214</lpage>
<pub-id pub-id-type="pmid">13366993</pub-id>
</element-citation>
</ref>
<ref id="B53">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Kim</surname>
<given-names>W</given-names>
</name><name>
<surname>Hecht</surname>
<given-names>MH</given-names>
</name></person-group>
<article-title>Sequence determinants of enhanced amyloidogenicity of Alzheimer A&#x003b2;42 peptide
relative to A&#x003b2;40</article-title>
<source>J Biol Chem</source>
<year>2005</year>
<volume>280</volume>
<fpage>35069</fpage>
<lpage>35076</lpage>
<pub-id pub-id-type="pmid">16079141</pub-id>
</element-citation>
</ref>
<ref id="B54">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Kim</surname>
<given-names>W</given-names>
</name><name>
<surname>Hecht</surname>
<given-names>MH</given-names>
</name></person-group>
<article-title>Mutations enhance the aggregation propensity of the Alzheimer's Abeta
peptide</article-title>
<source>J Mol Biol</source>
<year>2008</year>
<volume>377</volume>
<fpage>565</fpage>
<lpage>574</lpage>
<pub-id pub-id-type="pmid">18258258</pub-id>
</element-citation>
</ref>
<ref id="B57">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Ko</surname>
<given-names>LW</given-names>
</name><name>
<surname>Sheu</surname>
<given-names>KF</given-names>
</name><name>
<surname>Thaler</surname>
<given-names>HT</given-names>
</name><name>
<surname>Markesbery</surname>
<given-names>WR</given-names>
</name><name>
<surname>Blass</surname>
<given-names>JP</given-names>
</name></person-group>
<article-title>Selective loss of KGDHC-enriched neurons in Alzheimer temporal cortex: does
mitochondrial variation contribute to selective vulnerability?</article-title>
<source>J Mol Neurosci</source>
<year>2001</year>
<volume>17</volume>
<fpage>361</fpage>
<lpage>369</lpage>
<pub-id pub-id-type="pmid">11859932</pub-id>
</element-citation>
</ref>
<ref id="B55">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Kodaki</surname>
<given-names>T</given-names>
</name><name>
<surname>Yamashita</surname>
<given-names>S</given-names>
</name></person-group>
<article-title>Yeast phosphatidylethanolamine methylation pathway. Cloning and characterization of
two distinct methyltransferase genes</article-title>
<source>J Biol Chem</source>
<year>1987</year>
<volume>262</volume>
<fpage>15428</fpage>
<lpage>15435</lpage>
<pub-id pub-id-type="pmid">2445736</pub-id>
</element-citation>
</ref>
<ref id="B56">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Komano</surname>
<given-names>H</given-names>
</name><name>
<surname>Seeger</surname>
<given-names>M</given-names>
</name><name>
<surname>Gandy</surname>
<given-names>S</given-names>
</name><name>
<surname>Wang</surname>
<given-names>GT</given-names>
</name><name>
<surname>Krafft</surname>
<given-names>GA</given-names>
</name><name>
<surname>Fuller</surname>
<given-names>RS</given-names>
</name></person-group>
<article-title>Involvement of cell surface glycosyl-phosphatidylinositol-linked aspartyl proteases
in alpha-secretase-type cleavage and ectodomain solubilization of human Alzheimer beta-amyloid
precursor protein in yeast</article-title>
<source>J Biol Chem</source>
<year>1998</year>
<volume>273</volume>
<fpage>31648</fpage>
<lpage>31651</lpage>
<pub-id pub-id-type="pmid">9822624</pub-id>
</element-citation>
</ref>
<ref id="B58">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>LaFerla</surname>
<given-names>FM</given-names>
</name><name>
<surname>Green</surname>
<given-names>KN</given-names>
</name><name>
<surname>Oddo</surname>
<given-names>S</given-names>
</name></person-group>
<article-title>Intracellular amyloid-beta in Alzheimer's disease</article-title>
<source>Nat Rev Neurosci</source>
<year>2007</year>
<volume>8</volume>
<fpage>499</fpage>
<lpage>509</lpage>
<pub-id pub-id-type="pmid">17551515</pub-id>
</element-citation>
</ref>
<ref id="B59">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Langui</surname>
<given-names>D</given-names>
</name><name>
<surname>Girardot</surname>
<given-names>N</given-names>
</name><name>
<surname>El Hachimi</surname>
<given-names>KH</given-names>
</name><name>
<surname>Allinquant</surname>
<given-names>B</given-names>
</name><name>
<surname>Blanchard</surname>
<given-names>V</given-names>
</name><name>
<surname>Pradier</surname>
<given-names>L</given-names>
</name><name>
<surname>Duyckaerts</surname>
<given-names>C</given-names>
</name></person-group>
<article-title>Subcellular topography of neuronal Abeta peptide in APPxPS1 transgenic
mice</article-title>
<source>Am J Pathol</source>
<year>2004</year>
<volume>165</volume>
<fpage>1465</fpage>
<lpage>1477</lpage>
<pub-id pub-id-type="pmid">15509518</pub-id>
</element-citation>
</ref>
<ref id="B60">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Lemkul</surname>
<given-names>JA</given-names>
</name><name>
<surname>Bevan</surname>
<given-names>DR</given-names>
</name></person-group>
<article-title>Lipid composition influences the release of Alzheimer's amyloid &#x003b2;-peptide
from membranes</article-title>
<source>Protein Sci</source>
<year>2011</year>
<volume>20</volume>
<fpage>1530</fpage>
<lpage>1545</lpage>
<pub-id pub-id-type="pmid">21692120</pub-id>
</element-citation>
</ref>
<ref id="B61">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Lesne</surname>
<given-names>S</given-names>
</name><name>
<surname>Koh</surname>
<given-names>MT</given-names>
</name><name>
<surname>Kotilinek</surname>
<given-names>L</given-names>
</name><name>
<surname>Kayed</surname>
<given-names>R</given-names>
</name><name>
<surname>Glabe</surname>
<given-names>CG</given-names>
</name><name>
<surname>Yang</surname>
<given-names>A</given-names>
</name><name>
<surname>Gallagher</surname>
<given-names>M</given-names>
</name><name>
<surname>Ashe</surname>
<given-names>KH</given-names>
</name></person-group>
<article-title>A specific amyloid-beta protein assembly in the brain impairs memory</article-title>
<source>Nature</source>
<year>2006</year>
<volume>440</volume>
<fpage>352</fpage>
<lpage>357</lpage>
<pub-id pub-id-type="pmid">16541076</pub-id>
</element-citation>
</ref>
<ref id="B62">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Lesne</surname>
<given-names>S</given-names>
</name><name>
<surname>Kotilinek</surname>
<given-names>L</given-names>
</name></person-group>
<article-title>Amyloid plaques and amyloid-beta oligomers: an ongoing debate</article-title>
<source>J Neurosci</source>
<year>2005</year>
<volume>25</volume>
<fpage>9319</fpage>
<lpage>9320</lpage>
<pub-id pub-id-type="pmid">16221839</pub-id>
</element-citation>
</ref>
<ref id="B63">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Li</surname>
<given-names>G</given-names>
</name><name>
<surname>Rauscher</surname>
<given-names>S</given-names>
</name><name>
<surname>Baud</surname>
<given-names>S</given-names>
</name><name>
<surname>Pomes</surname>
<given-names>R</given-names>
</name></person-group>
<article-title>Binding of inositol stereoisomers to model amyloidogenic peptides</article-title>
<source>J Phys Chem B</source>
<year>2012</year>
<volume>116</volume>
<fpage>1111</fpage>
<lpage>1119</lpage>
<pub-id pub-id-type="pmid">22091989</pub-id>
</element-citation>
</ref>
<ref id="B64">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Loewen</surname>
<given-names>CJ</given-names>
</name><name>
<surname>Roy</surname>
<given-names>A</given-names>
</name><name>
<surname>Levine</surname>
<given-names>TP</given-names>
</name></person-group>
<article-title>A conserved ER targeting motif in three families of lipid binding proteins and in
Opi1p binds VAP</article-title>
<source>EMBO J</source>
<year>2003</year>
<volume>22</volume>
<fpage>2025</fpage>
<lpage>2035</lpage>
<pub-id pub-id-type="pmid">12727870</pub-id>
</element-citation>
</ref>
<ref id="B65">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Loewy</surname>
<given-names>BS</given-names>
</name><name>
<surname>Henry</surname>
<given-names>SA</given-names>
</name></person-group>
<article-title>The <italic>INO2</italic> and <italic>INO4</italic> loci of <italic>Saccharomyces
cerevisiae</italic> are pleiotropic regulatory genes</article-title>
<source>Mol Cell Biol</source>
<year>1984</year>
<volume>4</volume>
<fpage>2479</fpage>
<lpage>2485</lpage>
<pub-id pub-id-type="pmid">6392853</pub-id>
</element-citation>
</ref>
<ref id="B71">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Ma</surname>
<given-names>K</given-names>
</name><name>
<surname>Thomason</surname>
<given-names>LA</given-names>
</name><name>
<surname>McLaurin</surname>
<given-names>J</given-names>
</name></person-group>
<article-title>scyllo-Inositol, preclinical, and clinical data for Alzheimer's
disease</article-title>
<source>Adv Pharmacol</source>
<year>2012</year>
<volume>64</volume>
<fpage>177</fpage>
<lpage>212</lpage>
<pub-id pub-id-type="pmid">22840748</pub-id>
</element-citation>
</ref>
<ref id="B66">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Macreadie</surname>
<given-names>I</given-names>
</name><name>
<surname>Lotfi-Miri</surname>
<given-names>M</given-names>
</name><name>
<surname>Mohotti</surname>
<given-names>S</given-names>
</name><name>
<surname>Shapira</surname>
<given-names>D</given-names>
</name><name>
<surname>Bennett</surname>
<given-names>L</given-names>
</name><name>
<surname>Varghese</surname>
<given-names>J</given-names>
</name></person-group>
<article-title>Validation of folate in a convenient yeast assay suited for identification of
inhibitors of Alzheimer's amyloid-beta aggregation</article-title>
<source>J Alzheimers Dis</source>
<year>2008</year>
<volume>15</volume>
<fpage>391</fpage>
<lpage>396</lpage>
<pub-id pub-id-type="pmid">18997292</pub-id>
</element-citation>
</ref>
<ref id="B67">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Maltseva</surname>
<given-names>E</given-names>
</name><name>
<surname>Brezesinski</surname>
<given-names>G</given-names>
</name></person-group>
<article-title>Adsorption of amyloid beta (1-40) peptide to phosphatidylethanolamine
monolayers</article-title>
<source>Chemphyschem</source>
<year>2004</year>
<volume>5</volume>
<fpage>1185</fpage>
<lpage>1190</lpage>
<pub-id pub-id-type="pmid">15446741</pub-id>
</element-citation>
</ref>
<ref id="B68">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Maltseva</surname>
<given-names>E</given-names>
</name><name>
<surname>Kerth</surname>
<given-names>A</given-names>
</name><name>
<surname>Blume</surname>
<given-names>A</given-names>
</name><name>
<surname>Mohwald</surname>
<given-names>H</given-names>
</name><name>
<surname>Brezesinski</surname>
<given-names>G</given-names>
</name></person-group>
<article-title>Adsorption of amyloid beta (1-40) peptide at phospholipid monolayers</article-title>
<source>Chembiochem</source>
<year>2005</year>
<volume>6</volume>
<fpage>1817</fpage>
<lpage>1824</lpage>
<pub-id pub-id-type="pmid">16175542</pub-id>
</element-citation>
</ref>
<ref id="B69">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Manczak</surname>
<given-names>M</given-names>
</name><name>
<surname>Anekonda</surname>
<given-names>TS</given-names>
</name><name>
<surname>Henson</surname>
<given-names>E</given-names>
</name><name>
<surname>Park</surname>
<given-names>BS</given-names>
</name><name>
<surname>Quinn</surname>
<given-names>J</given-names>
</name><name>
<surname>Reddy</surname>
<given-names>PH</given-names>
</name></person-group>
<article-title>Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons:
implications for free radical generation and oxidative damage in disease progression</article-title>
<source>Hum Mol Genet</source>
<year>2006</year>
<volume>15</volume>
<fpage>1437</fpage>
<lpage>1449</lpage>
<pub-id pub-id-type="pmid">16551656</pub-id>
</element-citation>
</ref>
<ref id="B70">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Masters</surname>
<given-names>CL</given-names>
</name><name>
<surname>Simms</surname>
<given-names>G</given-names>
</name><name>
<surname>Weinman</surname>
<given-names>NA</given-names>
</name><name>
<surname>Multhaup</surname>
<given-names>G</given-names>
</name><name>
<surname>McDonald</surname>
<given-names>BL</given-names>
</name><name>
<surname>Beyreuther</surname>
<given-names>K</given-names>
</name></person-group>
<article-title>Amyloid plaque core protein in Alzheimer disease and Down syndrome</article-title>
<source>Proc Natl Acad Sci USA</source>
<year>1985</year>
<volume>82</volume>
<fpage>4245</fpage>
<lpage>4249</lpage>
<pub-id pub-id-type="pmid">3159021</pub-id>
</element-citation>
</ref>
<ref id="B72">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>McCammon</surname>
<given-names>MT</given-names>
</name><name>
<surname>Epstein</surname>
<given-names>CB</given-names>
</name><name>
<surname>Przybyla-Zawislak</surname>
<given-names>B</given-names>
</name><name>
<surname>McAlister-Henn</surname>
<given-names>L</given-names>
</name><name>
<surname>Butow</surname>
<given-names>RA</given-names>
</name></person-group>
<article-title>Global transcription analysis of Krebs tricarboxylic acid cycle mutants reveals an
alternating pattern of gene expression and effects on hypoxic and oxidative genes</article-title>
<source>Mol Biol Cell</source>
<year>2003</year>
<volume>14</volume>
<fpage>958</fpage>
<lpage>972</lpage>
<pub-id pub-id-type="pmid">12631716</pub-id>
</element-citation>
</ref>
<ref id="B73">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>McGraw</surname>
<given-names>P</given-names>
</name><name>
<surname>Henry</surname>
<given-names>SA</given-names>
</name></person-group>
<article-title>Mutations in the <italic>Saccharomyces cerevisiae OPI3</italic> gene: effects on
phospholipid methylation, growth and cross-pathway regulation of inositol synthesis</article-title>
<source>Genetics</source>
<year>1989</year>
<volume>122</volume>
<fpage>317</fpage>
<lpage>330</lpage>
<pub-id pub-id-type="pmid">2670666</pub-id>
</element-citation>
</ref>
<ref id="B75">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>McLaurin</surname>
<given-names>J</given-names>
</name><name>
<surname>Franklin</surname>
<given-names>T</given-names>
</name><name>
<surname>Chakrabartty</surname>
<given-names>A</given-names>
</name><name>
<surname>Fraser</surname>
<given-names>PE</given-names>
</name></person-group>
<article-title>Phosphatidylinositol and inositol involvement in Alzheimer amyloid-beta fibril growth
and arrest</article-title>
<source>J Mol Biol</source>
<year>1998</year>
<volume>278</volume>
<fpage>183</fpage>
<lpage>194</lpage>
<pub-id pub-id-type="pmid">9571042</pub-id>
</element-citation>
</ref>
<ref id="B76">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>McLaurin</surname>
<given-names>J</given-names>
</name><name>
<surname>Golomb</surname>
<given-names>R</given-names>
</name><name>
<surname>Jurewicz</surname>
<given-names>A</given-names>
</name><name>
<surname>Antel</surname>
<given-names>JP</given-names>
</name><name>
<surname>Fraser</surname>
<given-names>PE</given-names>
</name></person-group>
<article-title>Inositol stereoisomers stabilize an oligomeric aggregate of Alzheimer amyloid beta
peptide and inhibit abeta-induced toxicity</article-title>
<source>J Biol Chem</source>
<year>2000</year>
<volume>275</volume>
<fpage>18495</fpage>
<lpage>18502</lpage>
<pub-id pub-id-type="pmid">10764800</pub-id>
</element-citation>
</ref>
<ref id="B74">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>McLaurin</surname>
<given-names>J</given-names>
</name><etal/></person-group>
<article-title>Cyclohexanehexol inhibitors of Abeta aggregation prevent and reverse Alzheimer
phenotype in a mouse model</article-title>
<source>Nat Med</source>
<year>2006</year>
<volume>12</volume>
<fpage>801</fpage>
<lpage>808</lpage>
<pub-id pub-id-type="pmid">16767098</pub-id>
</element-citation>
</ref>
<ref id="B77">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Morell</surname>
<given-names>M</given-names>
</name><name>
<surname>de Groot</surname>
<given-names>NS</given-names>
</name><name>
<surname>Vendrell</surname>
<given-names>J</given-names>
</name><name>
<surname>Aviles</surname>
<given-names>FX</given-names>
</name><name>
<surname>Ventura</surname>
<given-names>S</given-names>
</name></person-group>
<article-title>Linking amyloid protein aggregation and yeast survival</article-title>
<source>Mol Biosyst</source>
<year>2011</year>
<volume>7</volume>
<fpage>1121</fpage>
<lpage>1128</lpage>
<pub-id pub-id-type="pmid">21240401</pub-id>
</element-citation>
</ref>
<ref id="B78">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Naiki</surname>
<given-names>H</given-names>
</name><name>
<surname>Nakakuki</surname>
<given-names>K</given-names>
</name></person-group>
<article-title>First-order kinetic model of Alzheimer's beta-amyloid fibril extension in
vitro</article-title>
<source>Lab Invest</source>
<year>1996</year>
<volume>74</volume>
<fpage>374</fpage>
<lpage>383</lpage>
<pub-id pub-id-type="pmid">8780157</pub-id>
</element-citation>
</ref>
<ref id="B79">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Nitsch</surname>
<given-names>RM</given-names>
</name><name>
<surname>Blusztajn</surname>
<given-names>JK</given-names>
</name><name>
<surname>Pittas</surname>
<given-names>AG</given-names>
</name><name>
<surname>Slack</surname>
<given-names>BE</given-names>
</name><name>
<surname>Growdon</surname>
<given-names>JH</given-names>
</name><name>
<surname>Wurtman</surname>
<given-names>RJ</given-names>
</name></person-group>
<article-title>Evidence for a membrane defect in Alzheimer disease brain</article-title>
<source>Proc Natl Acad Sci USA</source>
<year>1992</year>
<volume>89</volume>
<fpage>1671</fpage>
<lpage>1675</lpage>
<pub-id pub-id-type="pmid">1311847</pub-id>
</element-citation>
</ref>
<ref id="B80">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Oh</surname>
<given-names>S</given-names>
</name><name>
<surname>Hong</surname>
<given-names>HS</given-names>
</name><name>
<surname>Hwang</surname>
<given-names>E</given-names>
</name><name>
<surname>Sim</surname>
<given-names>HJ</given-names>
</name><name>
<surname>Lee</surname>
<given-names>W</given-names>
</name><name>
<surname>Shin</surname>
<given-names>SJ</given-names>
</name><name>
<surname>Mook-Jung</surname>
<given-names>I</given-names>
</name></person-group>
<article-title>Amyloid peptide attenuates the proteasome activity in neuronal cells</article-title>
<source>Mech Ageing Dev</source>
<year>2005</year>
<volume>126</volume>
<fpage>1292</fpage>
<lpage>1299</lpage>
<pub-id pub-id-type="pmid">16153690</pub-id>
</element-citation>
</ref>
<ref id="B81">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Outeiro</surname>
<given-names>TF</given-names>
</name><name>
<surname>Lindquist</surname>
<given-names>S</given-names>
</name></person-group>
<article-title>Yeast cells provide insight into alpha-synuclein biology and
pathobiology</article-title>
<source>Science</source>
<year>2003</year>
<volume>302</volume>
<fpage>1772</fpage>
<lpage>1775</lpage>
<pub-id pub-id-type="pmid">14657500</pub-id>
</element-citation>
</ref>
<ref id="B82">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Park</surname>
<given-names>SK</given-names>
</name><name>
<surname>Pegan</surname>
<given-names>SD</given-names>
</name><name>
<surname>Mesecar</surname>
<given-names>AD</given-names>
</name><name>
<surname>Jungbauer</surname>
<given-names>LM</given-names>
</name><name>
<surname>LaDu</surname>
<given-names>MJ</given-names>
</name><name>
<surname>Liebman</surname>
<given-names>SW</given-names>
</name></person-group>
<article-title>Development and validation of a yeast high-throughput screen for inhibitors of
Abeta(4)(2) oligomerization</article-title>
<source>Dis Model Mech</source>
<year>2011</year>
<volume>4</volume>
<fpage>822</fpage>
<lpage>831</lpage>
<pub-id pub-id-type="pmid">21810907</pub-id>
</element-citation>
</ref>
<ref id="B83">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Rosenberger</surname>
<given-names>S</given-names>
</name><name>
<surname>Connerth</surname>
<given-names>M</given-names>
</name><name>
<surname>Zellnig</surname>
<given-names>G</given-names>
</name><name>
<surname>Daum</surname>
<given-names>G</given-names>
</name></person-group>
<article-title>Phosphatidylethanolamine synthesized by three different pathways is supplied to
peroxisomes of the yeast <italic>Saccharomyces cerevisiae</italic></article-title>
<source>Biochim Biophys Acta</source>
<year>2009</year>
<volume>1791</volume>
<fpage>379</fpage>
<lpage>387</lpage>
<pub-id pub-id-type="pmid">19830909</pub-id>
</element-citation>
</ref>
<ref id="B84">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Seilheimer</surname>
<given-names>B</given-names>
</name><name>
<surname>Bohrmann</surname>
<given-names>B</given-names>
</name><name>
<surname>Bondolfi</surname>
<given-names>L</given-names>
</name><name>
<surname>Muller</surname>
<given-names>F</given-names>
</name><name>
<surname>Stuber</surname>
<given-names>D</given-names>
</name><name>
<surname>Dobeli</surname>
<given-names>H</given-names>
</name></person-group>
<article-title>The toxicity of the Alzheimer's beta-amyloid peptide correlates with a distinct fiber
morphology</article-title>
<source>J Struct Biol</source>
<year>1997</year>
<volume>119</volume>
<fpage>59</fpage>
<lpage>71</lpage>
<pub-id pub-id-type="pmid">9216088</pub-id>
</element-citation>
</ref>
<ref id="B85">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Selkoe</surname>
<given-names>DJ</given-names>
</name></person-group>
<article-title>Amyloid protein and Alzheimer's disease</article-title>
<source>Sci Am</source>
<year>1991</year>
<volume>265</volume>
<fpage>78</fpage>
<comment>68&#x02013;71, 74&#x02013;66</comment>
<pub-id pub-id-type="pmid">1862333</pub-id>
</element-citation>
</ref>
<ref id="B86">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Selley</surname>
<given-names>ML</given-names>
</name></person-group>
<article-title>A metabolic link between <italic>S</italic>-adenosylhomocysteine and polyunsaturated
fatty acid metabolism in Alzheimer's disease</article-title>
<source>Neurobiol Aging</source>
<year>2007</year>
<volume>28</volume>
<fpage>1834</fpage>
<lpage>1839</lpage>
<pub-id pub-id-type="pmid">16996649</pub-id>
</element-citation>
</ref>
<ref id="B88">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Shi</surname>
<given-names>Q</given-names>
</name><name>
<surname>Xu</surname>
<given-names>H</given-names>
</name><name>
<surname>Yu</surname>
<given-names>H</given-names>
</name><name>
<surname>Zhang</surname>
<given-names>N</given-names>
</name><name>
<surname>Ye</surname>
<given-names>Y</given-names>
</name><name>
<surname>Estevez</surname>
<given-names>AG</given-names>
</name><name>
<surname>Deng</surname>
<given-names>H</given-names>
</name><name>
<surname>Gibson</surname>
<given-names>GE</given-names>
</name></person-group>
<article-title>Inactivation and reactivation of the mitochondrial alpha-ketoglutarate dehydrogenase
complex</article-title>
<source>J Biol Chem</source>
<year>2011</year>
<volume>286</volume>
<fpage>17640</fpage>
<lpage>17648</lpage>
<pub-id pub-id-type="pmid">21454586</pub-id>
</element-citation>
</ref>
<ref id="B87">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Shimohama</surname>
<given-names>S</given-names>
</name><name>
<surname>Tanino</surname>
<given-names>H</given-names>
</name><name>
<surname>Sumida</surname>
<given-names>Y</given-names>
</name><name>
<surname>Tsuda</surname>
<given-names>J</given-names>
</name><name>
<surname>Fujimoto</surname>
<given-names>S</given-names>
</name></person-group>
<article-title>Alteration of myo-inositol monophosphatase in Alzheimer's disease
brains</article-title>
<source>Neurosci Lett</source>
<year>1998</year>
<volume>245</volume>
<fpage>159</fpage>
<lpage>162</lpage>
<pub-id pub-id-type="pmid">9605480</pub-id>
</element-citation>
</ref>
<ref id="B89">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Silva</surname>
<given-names>DF</given-names>
</name><name>
<surname>Esteves</surname>
<given-names>AR</given-names>
</name><name>
<surname>Oliveira</surname>
<given-names>CR</given-names>
</name><name>
<surname>Cardoso</surname>
<given-names>SM</given-names>
</name></person-group>
<article-title>Mitochondria: the common upstream driver of amyloid-beta and tau pathology in
Alzheimer's disease</article-title>
<source>Curr Alzheimer Res</source>
<year>2011</year>
<volume>8</volume>
<fpage>563</fpage>
<lpage>572</lpage>
<pub-id pub-id-type="pmid">21244356</pub-id>
</element-citation>
</ref>
<ref id="B90">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Simmons</surname>
<given-names>LK</given-names>
</name><etal/></person-group>
<article-title>Secondary structure of amyloid beta peptide correlates with neurotoxic activity in
vitro</article-title>
<source>Mol Pharmacol</source>
<year>1994</year>
<volume>45</volume>
<fpage>373</fpage>
<lpage>379</lpage>
<pub-id pub-id-type="pmid">8145724</pub-id>
</element-citation>
</ref>
<ref id="B91">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Summers</surname>
<given-names>EF</given-names>
</name><name>
<surname>Letts</surname>
<given-names>VA</given-names>
</name><name>
<surname>McGraw</surname>
<given-names>P</given-names>
</name><name>
<surname>Henry</surname>
<given-names>SA</given-names>
</name></person-group>
<article-title><italic>Saccharomyces cerevisiae cho2</italic> mutants are deficient in phospholipid
methylation and cross-pathway regulation of inositol synthesis</article-title>
<source>Genetics</source>
<year>1988</year>
<volume>120</volume>
<fpage>909</fpage>
<lpage>922</lpage>
<pub-id pub-id-type="pmid">3066687</pub-id>
</element-citation>
</ref>
<ref id="B92">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Tajima</surname>
<given-names>Y</given-names>
</name><etal/></person-group>
<article-title>Lipidomic analysis of brain tissues and plasma in a mouse model expressing mutated
human amyloid precursor protein/tau for Alzheimer's disease</article-title>
<source>Lipids Health Dis</source>
<year>2013</year>
<volume>12</volume>
<fpage>68</fpage>
<pub-id pub-id-type="pmid">23659495</pub-id>
</element-citation>
</ref>
<ref id="B93">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Takahashi</surname>
<given-names>RH</given-names>
</name><name>
<surname>Milner</surname>
<given-names>TA</given-names>
</name><name>
<surname>Li</surname>
<given-names>F</given-names>
</name><name>
<surname>Nam</surname>
<given-names>EE</given-names>
</name><name>
<surname>Edgar</surname>
<given-names>MA</given-names>
</name><name>
<surname>Yamaguchi</surname>
<given-names>H</given-names>
</name><name>
<surname>Beal</surname>
<given-names>MF</given-names>
</name><name>
<surname>Xu</surname>
<given-names>H</given-names>
</name><name>
<surname>Greengard</surname>
<given-names>P</given-names>
</name><name>
<surname>Gouras</surname>
<given-names>GK</given-names>
</name></person-group>
<article-title>Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is
associated with synaptic pathology</article-title>
<source>Am J Pathol</source>
<year>2002</year>
<volume>161</volume>
<fpage>1869</fpage>
<lpage>1879</lpage>
<pub-id pub-id-type="pmid">12414533</pub-id>
</element-citation>
</ref>
<ref id="B94">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Terzi</surname>
<given-names>E</given-names>
</name><name>
<surname>Holzemann</surname>
<given-names>G</given-names>
</name><name>
<surname>Seelig</surname>
<given-names>J</given-names>
</name></person-group>
<article-title>Interaction of Alzheimer beta-amyloid peptide(1-40) with lipid
membranes</article-title>
<source>Biochemistry</source>
<year>1997</year>
<volume>36</volume>
<fpage>14845</fpage>
<lpage>14852</lpage>
<pub-id pub-id-type="pmid">9398206</pub-id>
</element-citation>
</ref>
<ref id="B95">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Traven</surname>
<given-names>A</given-names>
</name><name>
<surname>Wong</surname>
<given-names>JM</given-names>
</name><name>
<surname>Xu</surname>
<given-names>D</given-names>
</name><name>
<surname>Sopta</surname>
<given-names>M</given-names>
</name><name>
<surname>Ingles</surname>
<given-names>CJ</given-names>
</name></person-group>
<article-title>Interorganellar communication. Altered nuclear gene expression profiles in a yeast
mitochondrial DNA mutant</article-title>
<source>J Biol Chem</source>
<year>2001</year>
<volume>276</volume>
<fpage>4020</fpage>
<lpage>4027</lpage>
<pub-id pub-id-type="pmid">11054416</pub-id>
</element-citation>
</ref>
<ref id="B96">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Treusch</surname>
<given-names>S</given-names>
</name><etal/></person-group>
<article-title>Functional links between Abeta toxicity, endocytic trafficking, and Alzheimer's
disease risk factors in yeast</article-title>
<source>Science</source>
<year>2011</year>
<volume>334</volume>
<fpage>1241</fpage>
<lpage>1245</lpage>
<pub-id pub-id-type="pmid">22033521</pub-id>
</element-citation>
</ref>
<ref id="B97">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Tzagoloff</surname>
<given-names>A</given-names>
</name><name>
<surname>Dieckmann</surname>
<given-names>CL</given-names>
</name></person-group>
<article-title><italic>PET</italic> genes of <italic>Saccharomyces
cerevisiae</italic></article-title>
<source>Microbiol Rev</source>
<year>1990</year>
<volume>54</volume>
<fpage>211</fpage>
<lpage>225</lpage>
<pub-id pub-id-type="pmid">2215420</pub-id>
</element-citation>
</ref>
<ref id="B98">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Vandebroek</surname>
<given-names>T</given-names>
</name><name>
<surname>Terwel</surname>
<given-names>D</given-names>
</name><name>
<surname>Vanhelmont</surname>
<given-names>T</given-names>
</name><name>
<surname>Gysemans</surname>
<given-names>M</given-names>
</name><name>
<surname>Van Haesendonck</surname>
<given-names>C</given-names>
</name><name>
<surname>Engelborghs</surname>
<given-names>Y</given-names>
</name><name>
<surname>Winderickx</surname>
<given-names>J</given-names>
</name><name>
<surname>Van Leuven</surname>
<given-names>F</given-names>
</name></person-group>
<article-title>Microtubule binding and clustering of human Tau-4R and Tau-P301L proteins isolated
from yeast deficient in orthologues of glycogen synthase kinase-3beta or cdk5</article-title>
<source>J Biol Chem</source>
<year>2006</year>
<volume>281</volume>
<fpage>25388</fpage>
<lpage>25397</lpage>
<pub-id pub-id-type="pmid">16818492</pub-id>
</element-citation>
</ref>
<ref id="B99">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Vandebroek</surname>
<given-names>T</given-names>
</name><name>
<surname>Vanhelmont</surname>
<given-names>T</given-names>
</name><name>
<surname>Terwel</surname>
<given-names>D</given-names>
</name><name>
<surname>Borghgraef</surname>
<given-names>P</given-names>
</name><name>
<surname>Lemaire</surname>
<given-names>K</given-names>
</name><name>
<surname>Snauwaert</surname>
<given-names>J</given-names>
</name><name>
<surname>Wera</surname>
<given-names>S</given-names>
</name><name>
<surname>Van Leuven</surname>
<given-names>F</given-names>
</name><name>
<surname>Winderickx</surname>
<given-names>J</given-names>
</name></person-group>
<article-title>Identification and isolation of a hyperphosphorylated, conformationally changed
intermediate of human protein tau expressed in yeast</article-title>
<source>Biochemistry</source>
<year>2005</year>
<volume>44</volume>
<fpage>11466</fpage>
<lpage>11475</lpage>
<pub-id pub-id-type="pmid">16114883</pub-id>
</element-citation>
</ref>
<ref id="B100">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Vanhelmont</surname>
<given-names>T</given-names>
</name><name>
<surname>Vandebroek</surname>
<given-names>T</given-names>
</name><name>
<surname>De Vos</surname>
<given-names>A</given-names>
</name><name>
<surname>Terwel</surname>
<given-names>D</given-names>
</name><name>
<surname>Lemaire</surname>
<given-names>K</given-names>
</name><name>
<surname>Anandhakumar</surname>
<given-names>J</given-names>
</name><name>
<surname>Franssens</surname>
<given-names>V</given-names>
</name><name>
<surname>Swinnen</surname>
<given-names>E</given-names>
</name><name>
<surname>Van Leuven</surname>
<given-names>F</given-names>
</name><name>
<surname>Winderickx</surname>
<given-names>J</given-names>
</name></person-group>
<article-title>Serine-409 phosphorylation and oxidative damage define aggregation of human protein
tau in yeast</article-title>
<source>FEMS Yeast Res</source>
<year>2010</year>
<volume>10</volume>
<fpage>992</fpage>
<lpage>1005</lpage>
<pub-id pub-id-type="pmid">20662935</pub-id>
</element-citation>
</ref>
<ref id="B101">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Villar-Pique</surname>
<given-names>A</given-names>
</name><name>
<surname>Ventura</surname>
<given-names>S</given-names>
</name></person-group>
<article-title>Protein aggregation propensity is a crucial determinant of intracellular inclusion
formation and quality control degradation</article-title>
<source>Biochim Biophys Acta</source>
<year>2013</year>
<volume>1833</volume>
<fpage>2714</fpage>
<lpage>2724</lpage>
<pub-id pub-id-type="pmid">23856334</pub-id>
</element-citation>
</ref>
<ref id="B102">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Waldo</surname>
<given-names>GS</given-names>
</name><name>
<surname>Standish</surname>
<given-names>BM</given-names>
</name><name>
<surname>Berendzen</surname>
<given-names>J</given-names>
</name><name>
<surname>Terwilliger</surname>
<given-names>TC</given-names>
</name></person-group>
<article-title>Rapid protein-folding assay using green fluorescent protein</article-title>
<source>Nat Biotechnol</source>
<year>1999</year>
<volume>17</volume>
<fpage>691</fpage>
<lpage>695</lpage>
<pub-id pub-id-type="pmid">10404163</pub-id>
</element-citation>
</ref>
<ref id="B103">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Willingham</surname>
<given-names>S</given-names>
</name><name>
<surname>Outeiro</surname>
<given-names>TF</given-names>
</name><name>
<surname>DeVit</surname>
<given-names>MJ</given-names>
</name><name>
<surname>Lindquist</surname>
<given-names>SL</given-names>
</name><name>
<surname>Muchowski</surname>
<given-names>PJ</given-names>
</name></person-group>
<article-title>Yeast genes that enhance the toxicity of a mutant huntingtin fragment or
alpha-synuclein</article-title>
<source>Science</source>
<year>2003</year>
<volume>302</volume>
<fpage>1769</fpage>
<lpage>1772</lpage>
<pub-id pub-id-type="pmid">14657499</pub-id>
</element-citation>
</ref>
<ref id="B104">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Winderickx</surname>
<given-names>J</given-names>
</name><name>
<surname>Delay</surname>
<given-names>C</given-names>
</name><name>
<surname>De Vos</surname>
<given-names>A</given-names>
</name><name>
<surname>Klinger</surname>
<given-names>H</given-names>
</name><name>
<surname>Pellens</surname>
<given-names>K</given-names>
</name><name>
<surname>Vanhelmont</surname>
<given-names>T</given-names>
</name><name>
<surname>Van Leuven</surname>
<given-names>F</given-names>
</name><name>
<surname>Zabrocki</surname>
<given-names>P</given-names>
</name></person-group>
<article-title>Protein folding diseases and neurodegeneration: lessons learned from
yeast</article-title>
<source>Biochim Biophys Acta</source>
<year>2008</year>
<volume>1783</volume>
<fpage>1381</fpage>
<lpage>1395</lpage>
<pub-id pub-id-type="pmid">18298958</pub-id>
</element-citation>
</ref>
<ref id="B105">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Winzeler</surname>
<given-names>EA</given-names>
</name><etal/></person-group>
<article-title>Functional characterization of the <italic>S. cerevisiae</italic> genome by gene
deletion and parallel analysis</article-title>
<source>Science</source>
<year>1999</year>
<volume>285</volume>
<fpage>901</fpage>
<lpage>906</lpage>
<pub-id pub-id-type="pmid">10436161</pub-id>
</element-citation>
</ref>
<ref id="B106">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Wurth</surname>
<given-names>C</given-names>
</name><name>
<surname>Guimard</surname>
<given-names>NK</given-names>
</name><name>
<surname>Hecht</surname>
<given-names>MH</given-names>
</name></person-group>
<article-title>Mutations that reduce aggregation of the Alzheimer's Abeta42 peptide: an unbiased
search for the sequence determinants of Abeta amyloidogenesis</article-title>
<source>J Mol Biol</source>
<year>2002</year>
<volume>319</volume>
<fpage>1279</fpage>
<lpage>1290</lpage>
<pub-id pub-id-type="pmid">12079364</pub-id>
</element-citation>
</ref>
<ref id="B107">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Younkin</surname>
<given-names>SG</given-names>
</name></person-group>
<article-title>The role of Abeta 42 in Alzheimer's disease</article-title>
<source>J Physiol</source>
<year>1998</year>
<volume>92</volume>
<fpage>289</fpage>
<lpage>292</lpage>
</element-citation>
</ref>
<ref id="B108">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Zhang</surname>
<given-names>W</given-names>
</name><name>
<surname>Espinoza</surname>
<given-names>D</given-names>
</name><name>
<surname>Hines</surname>
<given-names>V</given-names>
</name><name>
<surname>Innis</surname>
<given-names>M</given-names>
</name><name>
<surname>Mehta</surname>
<given-names>P</given-names>
</name><name>
<surname>Miller</surname>
<given-names>DL</given-names>
</name></person-group>
<article-title>Characterization of beta-amyloid peptide precursor processing by the yeast Yap3 and
Mkc7 proteases</article-title>
<source>Biochim Biophys Acta</source>
<year>1997</year>
<volume>1359</volume>
<fpage>110</fpage>
<lpage>122</lpage>
<pub-id pub-id-type="pmid">9409808</pub-id>
</element-citation>
</ref>
<ref id="B109">
<element-citation publication-type="journal">
<person-group person-group-type="author"><name>
<surname>Zhang</surname>
<given-names>H</given-names>
</name><name>
<surname>Komano</surname>
<given-names>H</given-names>
</name><name>
<surname>Fuller</surname>
<given-names>RS</given-names>
</name><name>
<surname>Gandy</surname>
<given-names>SE</given-names>
</name><name>
<surname>Frail</surname>
<given-names>DE</given-names>
</name></person-group>
<article-title>Proteolytic processing and secretion of human beta-amyloid precursor protein in
yeast. Evidence for a yeast secretase activity</article-title>
<source>J Biol Chem</source>
<year>1994</year>
<volume>269</volume>
<fpage>27799</fpage>
<lpage>27802</lpage>
<pub-id pub-id-type="pmid">7961704</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
